<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosone" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC3354003/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354003/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood" /><meta name="citation_authors" content="Ruymán Santana-Farré, Mercedes Mirecki-Garrido, Carlos Bocos, Luis A. Henríquez-Hernández, Nusrat Kahlon, Emilio Herrera, Gunnar Norstedt, Paolo Parini, Amilcar Flores-Morales, Leandro Fernández-Pérez" /><meta name="citation_date" content="2012" /><meta name="citation_issue" content="5" /><meta name="citation_volume" content="7" /><meta name="citation_doi" content="10.1371/journal.pone.0037386" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3354003/?report=abstract" /><meta name="citation_pmid" content="22666351" /><meta name="DC.Title" content="Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Ruymán Santana-Farré" /><meta name="DC.Contributor" content="Mercedes Mirecki-Garrido" /><meta name="DC.Contributor" content="Carlos Bocos" /><meta name="DC.Contributor" content="Luis A. Henríquez-Hernández" /><meta name="DC.Contributor" content="Nusrat Kahlon" /><meta name="DC.Contributor" content="Emilio Herrera" /><meta name="DC.Contributor" content="Gunnar Norstedt" /><meta name="DC.Contributor" content="Paolo Parini" /><meta name="DC.Contributor" content="Amilcar Flores-Morales" /><meta name="DC.Contributor" content="Leandro Fernández-Pérez" /><meta name="DC.Date" content="2012" /><meta name="DC.Identifier" content="10.1371/journal.pone.0037386" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood" /><meta property="og:type" content="article" /><meta property="og:description" content="Thyroid hormones are required for normal growth and development in mammals. Congenital-neonatal hypothyroidism (CH) has a profound impact on physiology, but its specific influence in liver is less understood. Here, we studied how CH influences the liver ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354003/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'/pmc/utils/ctxp/'" /><script type="text/javascript" src="/corehtml/pmc/ctxp/jquery.citationexporter.js">//</script><link rel="stylesheet" href="/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3354003/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3354003/pdf/pone.0037386.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="F4FC690BB4D241A1000000000055004B.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/209567/">v.7(5); 2012</a></li><li class="accid">PMC3354003</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0037386" ref="reftype=publisher&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS One</span>. 2012; 7(5): e37386. </span></div><div><span class="fm-vol-iss-date">Published online 2012 May 16. </span>  <span class="doi">doi:  <a href="//dx.doi.org/10.1371%2Fjournal.pone.0037386" target="pmc_ext" ref="reftype=other&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1371/journal.pone.0037386</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3354003</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/22666351">22666351</a></div></div></div></div></div><h1 class="content-title">Influence of Neonatal Hypothyroidism on Hepatic Gene Expression and Lipid Metabolism in Adulthood</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Santana-Farr%26%23x000e9%3B%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662109352496" co-class="co-affbox">Ruym&#x000e1;n Santana-Farr&#x000e9;</a>,<sup>#</sup><sup>
1
</sup> <a href="/pubmed/?term=Mirecki-Garrido%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662148347664" co-class="co-affbox">Mercedes Mirecki-Garrido</a>,<sup>#</sup><sup>
1
</sup> <a href="/pubmed/?term=Bocos%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662109277584" co-class="co-affbox">Carlos Bocos</a>,<sup>
2
</sup> <a href="/pubmed/?term=Henr%26%23x000ed%3Bquez-Hern%26%23x000e1%3Bndez%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662108210112" co-class="co-affbox">Luis A. Henr&#x000ed;quez-Hern&#x000e1;ndez</a>,<sup>
1
</sup> <a href="/pubmed/?term=Kahlon%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662110478048" co-class="co-affbox">Nusrat Kahlon</a>,<sup>
3
</sup> <a href="/pubmed/?term=Herrera%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662074746368" co-class="co-affbox">Emilio Herrera</a>,<sup>
2
</sup> <a href="/pubmed/?term=Norstedt%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662109828016" co-class="co-affbox">Gunnar Norstedt</a>,<sup>
3
</sup> <a href="/pubmed/?term=Parini%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662112428320" co-class="co-affbox">Paolo Parini</a>,<sup>
4
</sup> <a href="/pubmed/?term=Flores-Morales%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662073792928" co-class="co-affbox">Amilcar Flores-Morales</a>,<sup>
3
,</sup><sup>
5
</sup> and  <a href="/pubmed/?term=Fern%26%23x000e1%3Bndez-P%26%23x000e9%3Brez%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351" class="affpopup" co-rid="_co_idm140662069943008" co-class="co-affbox">Leandro Fern&#x000e1;ndez-P&#x000e9;rez</a><sup>
1
,</sup><sup>
*
</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140662109352496"><h3 class="no_margin">Ruym&#x000e1;n Santana-Farr&#x000e9;</h3><p>  <sup>1</sup>  Department of Clinical Sciences, Molecular and Translational Endocrinology Group, University of Las Palmas de GC &#x02013; Cancer Research Institute of The Canary Islands (ICIC), Las Palmas de Gran Canaria, Spain,   </p><div>Find articles by <a href="/pubmed/?term=Santana-Farr%26%23x000e9%3B%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Ruym&#x000e1;n Santana-Farr&#x000e9;</a></div></div><div id="_co_idm140662148347664"><h3 class="no_margin">Mercedes Mirecki-Garrido</h3><p>  <sup>1</sup>  Department of Clinical Sciences, Molecular and Translational Endocrinology Group, University of Las Palmas de GC &#x02013; Cancer Research Institute of The Canary Islands (ICIC), Las Palmas de Gran Canaria, Spain,   </p><div>Find articles by <a href="/pubmed/?term=Mirecki-Garrido%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Mercedes Mirecki-Garrido</a></div></div><div id="_co_idm140662109277584"><h3 class="no_margin">Carlos Bocos</h3><p>  <sup>2</sup>  Department of Biology, Faculties of Pharmacy and Medicine, University San Pablo-CEU, Madrid, Spain,   </p><div>Find articles by <a href="/pubmed/?term=Bocos%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Carlos Bocos</a></div></div><div id="_co_idm140662108210112"><h3 class="no_margin">Luis A. Henr&#x000ed;quez-Hern&#x000e1;ndez</h3><p>  <sup>1</sup>  Department of Clinical Sciences, Molecular and Translational Endocrinology Group, University of Las Palmas de GC &#x02013; Cancer Research Institute of The Canary Islands (ICIC), Las Palmas de Gran Canaria, Spain,   </p><div>Find articles by <a href="/pubmed/?term=Henr%26%23x000ed%3Bquez-Hern%26%23x000e1%3Bndez%20LA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Luis A. Henr&#x000ed;quez-Hern&#x000e1;ndez</a></div></div><div id="_co_idm140662110478048"><h3 class="no_margin">Nusrat Kahlon</h3><p>  <sup>3</sup>  Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden,   </p><div>Find articles by <a href="/pubmed/?term=Kahlon%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Nusrat Kahlon</a></div></div><div id="_co_idm140662074746368"><h3 class="no_margin">Emilio Herrera</h3><p>  <sup>2</sup>  Department of Biology, Faculties of Pharmacy and Medicine, University San Pablo-CEU, Madrid, Spain,   </p><div>Find articles by <a href="/pubmed/?term=Herrera%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Emilio Herrera</a></div></div><div id="_co_idm140662109828016"><h3 class="no_margin">Gunnar Norstedt</h3><p>  <sup>3</sup>  Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden,   </p><div>Find articles by <a href="/pubmed/?term=Norstedt%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Gunnar Norstedt</a></div></div><div id="_co_idm140662112428320"><h3 class="no_margin">Paolo Parini</h3><p>  <sup>4</sup>  Division of Clinical Chemistry, Department of Laboratory Medicine and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Karolinska Institute, Stockholm, Sweden,   </p><div>Find articles by <a href="/pubmed/?term=Parini%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Paolo Parini</a></div></div><div id="_co_idm140662073792928"><h3 class="no_margin">Amilcar Flores-Morales</h3><p>  <sup>3</sup>  Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden,   </p><p>  <sup>5</sup>  Novo Nordisk Center for Protein Research, University of Copenhagen, Copenhagen, Denmark,   </p><div>Find articles by <a href="/pubmed/?term=Flores-Morales%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Amilcar Flores-Morales</a></div></div><div id="_co_idm140662069943008"><h3 class="no_margin">Leandro Fern&#x000e1;ndez-P&#x000e9;rez</h3><p>  <sup>1</sup>  Department of Clinical Sciences, Molecular and Translational Endocrinology Group, University of Las Palmas de GC &#x02013; Cancer Research Institute of The Canary Islands (ICIC), Las Palmas de Gran Canaria, Spain,   </p><div>Find articles by <a href="/pubmed/?term=Fern%26%23x000e1%3Bndez-P%26%23x000e9%3Brez%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22666351">Leandro Fern&#x000e1;ndez-P&#x000e9;rez</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Jean-Marc Vanacker, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140662150740368_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  <sup>1</sup>  Department of Clinical Sciences, Molecular and Translational Endocrinology Group, University of Las Palmas de GC &#x02013; Cancer Research Institute of The Canary Islands (ICIC), Las Palmas de Gran Canaria, Spain,   </div><div class="fm-affl" lang="en" id="aff2">  <sup>2</sup>  Department of Biology, Faculties of Pharmacy and Medicine, University San Pablo-CEU, Madrid, Spain,   </div><div class="fm-affl" lang="en" id="aff3">  <sup>3</sup>  Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden,   </div><div class="fm-affl" lang="en" id="aff4">  <sup>4</sup>  Division of Clinical Chemistry, Department of Laboratory Medicine and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Karolinska Institute, Stockholm, Sweden,   </div><div class="fm-affl" lang="en" id="aff5">  <sup>5</sup>  Novo Nordisk Center for Protein Research, University of Copenhagen, Copenhagen, Denmark,   </div><div class="fm-affl" lang="en" id="edit1">Institut de G&#x000e9;nomique Fonctionnelle de Lyon, France</div><div><sup>#</sup>Contributed equally.</div><div id="cor1">* E-mail: <a href="mailto:dev@null" data-email="se.cgplu.ccd@zednanrefl" class="oemail">se.cgplu.ccd@zednanrefl</a></div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: LF-P AF-M CB GN EH. Performed the experiments: RS-F MM-G CB NK LF-P PP LH-H. Analyzed the data: LF-P AF-M PP GN CB. Wrote the paper: LF-P AF-M CB.</p></div></div><div class="togglers"><a href="#" class="pmctoggle" rid="idm140662150740368_ai idm140662074115184_ai idm140662072670032_ai">Author information <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140662150740368_an">Article notes <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140662150740368_cpl">Copyright and License information <span>►</span></a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140662150740368_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2011 Oct 5; Accepted 2012 Apr 19.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm140662150740368_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Santana-Farr&#x000e9; et al.</div><div class="fm-copyright half_rhythm"><div class="license">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div>This article has been <a href="/pmc/articles/PMC3354003/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140662110023760" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140662110023760title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">Thyroid hormones are required for normal growth and development in mammals. Congenital-neonatal hypothyroidism (CH) has a profound impact on physiology, but its specific influence in liver is less understood. Here, we studied how CH influences the liver gene expression program in adulthood. Pregnant rats were given the antithyroid drug methimazole (MMI) from GD12 until PND30 to induce CH in male offspring. Growth defects due to CH were evident as reductions in body weight and tail length from the second week of life. Once the MMI treatment was discontinued, the feed efficiency increased in CH, and this was accompanied by significant catch-up growth. On PND80, significant reductions in body mass, tail length, and circulating IGF-I levels remained in CH rats. Conversely, the mRNA levels of known GH target genes were significantly upregulated. The serum levels of thyroid hormones, cholesterol, and triglycerides showed no significant differences. In contrast, CH rats showed significant changes in the expression of hepatic genes involved in lipid metabolism, including an increased transcription of PPAR&#x003b1; and a reduced expression of genes involved in fatty acid and cholesterol uptake, cellular sterol efflux, triglyceride assembly, bile acid synthesis, and lipogenesis. These changes were associated with a decrease of intrahepatic lipids. Finally, CH rats responded to the onset of hypothyroidism in adulthood with a reduction of serum fatty acids and hepatic cholesteryl esters and to T3 replacement with an enhanced activation of malic enzyme. In summary, we provide <em>in vivo</em> evidence that neonatal hypothyroidism influences the hepatic transcriptional program and tissue sensitivity to hormone treatment in adulthood. This highlights the critical role that a euthyroid state during development plays on normal liver physiology in adulthood.</p></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p id="__p3" class="p p-first">The thyroid hormones (THs) are essential for development, growth, and metabolism <a href="#pone.0037386-Yen1" rid="pone.0037386-Yen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868659">[1]</a>, <a href="#pone.0037386-DeFelice1" rid="pone.0037386-DeFelice1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868621">[2]</a>, <a href="#pone.0037386-LeRoith1" rid="pone.0037386-LeRoith1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868600">[3]</a>. The physiological importance of the THs becomes evident under the condition of congenital-neonatal hypothyroidism (CH) <a href="#pone.0037386-DeFelice1" rid="pone.0037386-DeFelice1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868679">[2]</a>. If not treated immediately, CH has a profound impact on physiology and can permanently imprint neurological and endocrine systems, which, in turn, leads to mental retardation, growth arrest, and metabolic disturbances. During ontogeny, there exists a critical period when normal TH levels are required, and TH replacement after that period cannot correct the changes in gene expression that was caused by CH. This is exemplified by abnormal insulin-like growth factor binding protein (IGBFP)-2 expression in neonatal hypothyroid rats that can be corrected by TH replacement if started during the first week of life but not later <a href="#pone.0037386-NantoSalonen1" rid="pone.0037386-NantoSalonen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868622">[4]</a>.</p><p id="__p4">Most of the effects of the THs result from their interaction with TH receptors (TR), which can bind to the TH response element (TRE) located in several target genes <a href="#pone.0037386-Yen1" rid="pone.0037386-Yen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868669">[1]</a>. A TRE is present upstream of the rat GH gene <a href="#pone.0037386-Samuels1" rid="pone.0037386-Samuels1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868593">[5]</a>, the product of which has a significant role in body growth and metabolism in postnatal life <a href="#pone.0037386-LeRoith1" rid="pone.0037386-LeRoith1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868681">[3]</a>. GH expression is induced by T3 and reduced in hypothyroid states <a href="#pone.0037386-NantoSalonen2" rid="pone.0037386-NantoSalonen2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868634">[6]</a>, <a href="#pone.0037386-Mullis1" rid="pone.0037386-Mullis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868619">[7]</a>, <a href="#pone.0037386-Rasmussen1" rid="pone.0037386-Rasmussen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868665">[8]</a>. In fact, the growth-promoting effects of T3 can be largely explained by its ability to induce normal GH secretion and to regulate the expression patterns of the GH receptor in the liver and the IGF-I receptor in peripheral tissues <a href="#pone.0037386-Moreno1" rid="pone.0037386-Moreno1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868690">[9]</a>. Therefore, the THs might exert physiological actions on the liver through a direct transcriptional regulation of several target genes <a href="#pone.0037386-Yen1" rid="pone.0037386-Yen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868577">[1]</a> and indirect mechanisms (e.g., modulating actions of GH and metabolic sensors such as LXR) <a href="#pone.0037386-NantoSalonen2" rid="pone.0037386-NantoSalonen2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868561">[6]</a>, <a href="#pone.0037386-Mullis1" rid="pone.0037386-Mullis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868685">[7]</a>, <a href="#pone.0037386-Rasmussen1" rid="pone.0037386-Rasmussen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868626">[8]</a>, <a href="#pone.0037386-Moreno1" rid="pone.0037386-Moreno1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868569">[9]</a>, <a href="#pone.0037386-Hoogerbrugge1" rid="pone.0037386-Hoogerbrugge1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868609">[10]</a>, <a href="#pone.0037386-Lazar1" rid="pone.0037386-Lazar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868587">[11]</a>. In addition, it has been shown that the effects of the THs on glucose metabolism might also be dependent on their actions in the brain, which affect the autonomic control of peripheral metabolic tissues such as the adipose tissue in addition to the liver <a href="#pone.0037386-Sjogren1" rid="pone.0037386-Sjogren1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868656">[12]</a>, <a href="#pone.0037386-Klieverik1" rid="pone.0037386-Klieverik1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868636">[13]</a>, <a href="#pone.0037386-Vujovic1" rid="pone.0037386-Vujovic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868646">[14]</a>. These findings suggest that CH could cause permanent alterations in peripheral metabolic tissues through irreversible developmental alterations in the brain. The THs clearly have some lipid-lowering actions, as demonstrated by recent human studies <a href="#pone.0037386-Angelin1" rid="pone.0037386-Angelin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868642">[15]</a>. For example, the ability of THs to reduce plasma LDL-c levels has been explained by its capacity to increase the expression of LDL receptors and the activities of lipid-lowering enzymes in the liver. THs increase the number of LDL receptors without necessarily modifying their transcription, which supports a post-transcriptional regulation of these proteins <a href="#pone.0037386-Lopez1" rid="pone.0037386-Lopez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868630">[16]</a>. Some lipid-lowering enzymes are direct transcriptional targets. These are exemplified by the CYP7A1 gene <a href="#pone.0037386-Gullberg1" rid="pone.0037386-Gullberg1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868688">[17]</a>, <a href="#pone.0037386-Ness1" rid="pone.0037386-Ness1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868581">[18]</a>, the product of which has a major cholesterol-lowering activity. Malic enzyme (ME) and fatty acid synthase (FAS), two critical regulators of lipogenesis, are also directly regulated by the THs <a href="#pone.0037386-Fang1" rid="pone.0037386-Fang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868560">[19]</a>, <a href="#pone.0037386-GonzalezManchon1" rid="pone.0037386-GonzalezManchon1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868691">[20]</a>, <a href="#pone.0037386-Xiong1" rid="pone.0037386-Xiong1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868580">[21]</a>. In contrast, the effects of THs on other lipogenic genes such as sterol regulatory element-binding protein (SREBP)-1c are more controversial: THs induced SREBP1c expression in the livers of rats <a href="#pone.0037386-FloresMorales1" rid="pone.0037386-FloresMorales1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868612">[22]</a>, <a href="#pone.0037386-HenriquezHernandez1" rid="pone.0037386-HenriquezHernandez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868645">[23]</a>, whereas they strongly downregulated SREBP1c in the livers of mice <a href="#pone.0037386-Hashimoto1" rid="pone.0037386-Hashimoto1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868615">[24]</a>.</p><p id="__p5" class="p p-last">In rats, the serum concentrations of the THs are low at birth and increase progressively, reaching adult levels at approximately the third week of life when the maturation of the hypothalamus-pituitary-thyroid axis is achieved <a href="#pone.0037386-Rodd1" rid="pone.0037386-Rodd1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868565">[25]</a>. Administration of the antithyroid drug methimazole (MMI) to pregnant rats before the onset of fetal thyroid function is known to abolish both the maternal and fetal thyroid function <a href="#pone.0037386-MorrealedeEscobar1" rid="pone.0037386-MorrealedeEscobar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868627">[26]</a>. In this context, exposure to MMI during the fetal-neonatal period of life is an attractive model to study the influence of CH on the adult pattern of genes that are under the control of the THs during rat development <a href="#pone.0037386-NantoSalonen1" rid="pone.0037386-NantoSalonen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868620">[4]</a>. In addition, the disturbances in endocrine status during the neonatal period of life may affect the susceptibility to chronic diseases or biological insults in adulthood <a href="#pone.0037386-Vujovic1" rid="pone.0037386-Vujovic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868604">[14]</a>, <a href="#pone.0037386-Oppenheimer1" rid="pone.0037386-Oppenheimer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868652">[27]</a>, <a href="#pone.0037386-Holness1" rid="pone.0037386-Holness1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868662">[28]</a>, <a href="#pone.0037386-Kirby1" rid="pone.0037386-Kirby1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868660">[29]</a>, <a href="#pone.0037386-Cooke1" rid="pone.0037386-Cooke1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868571">[30]</a>. However, the precise mechanism whereby CH influences liver physiology in adulthood remains poorly understood. We hypothesized that CH might lead to changes in TH and/or GH action during development that have physiological repercussions in adulthood. Therefore, there were two aims of this study. First, we assessed the influence of CH on the somatotropic axis, liver gene expression, and serum and hepatic lipid biomarkers in adulthood. Second, we investigated how rats, which were transiently exposed to CH, adapted to the biological insult of the onset of hypothyroidism in adulthood. In the present study, we provide <em>in vivo</em> evidence that exposure to CH alters postnatal development, which influences the liver transcriptional program that is associated with altered lipid homeostasis and tissue sensitivity to hormones.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and Methods</h2><div id="s2a" class="sec sec-first"><h3>Materials</h3><p id="__p6" class="p p-first-last">Recombinant human GH was kindly donated by Pfizer Laboratories (Spain). Tri-Reagent and the rest of the products cited in this work were purchased from the Sigma Chemical Co. (St. Louis, MO), unless otherwise indicated.</p></div><div id="s2b" class="sec"><h3>Animal study design</h3><p id="__p7" class="p p-first-last">This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the University of Las Palmas de G.C. and conducted in accordance with European and Spanish laws and regulations. The protocol was approved by the Committee on the Ethics of Animal Experiments of the University of Las Palmas de G.C. (permit number: 2006-07824). All efforts were made to minimize suffering. Male Sprague-Dawley rats (n&#x0200a;=&#x0200a;6 per group) were used throughout these experiments. Animals were kept under a constant dark/light cycle in a controlled temperature (21&#x02013;23&#x000b0;C) environment and had free access to a standard diet (A04 SAFE; Panlab, Barcelona, Spain) and tap water throughout the experiment. For mating purposes, four females were housed overnight with two males starting at 21:00 h. Females were checked by 7:00 h the next morning, and the presence of a vaginal plug was designated as gestational day (GD) 0. Within 24 h after birth, excess pups were removed so that 8 pups were kept per dam. The indirect MMI exposure method (i.e., through maternal milk) utilized in this experiment has been extensively employed to induce a transitory congenital-neonatal hypothyroidism (CH) for the determination of short- and long-term physiological effects <a href="#pone.0037386-NantoSalonen1" rid="pone.0037386-NantoSalonen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868680">[4]</a>, <a href="#pone.0037386-MorrealedeEscobar1" rid="pone.0037386-MorrealedeEscobar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868590">[26]</a>, <a href="#pone.0037386-Kirby1" rid="pone.0037386-Kirby1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868576">[29]</a>, <a href="#pone.0037386-Cooke1" rid="pone.0037386-Cooke1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868623">[30]</a>. Briefly, 0.02% MMI was administered in the drinking water for pregnant rats from GD12 until weaning at post-natal day (PND) 30, which is when pups were mature enough to support their own nutritional needs. The MMI-containing water was changed twice per week. Untreated rats served as concurrent euthyroid and age-matched controls (INTACT). Rats that were weight paired with the CH groups were also included to control for the effects of reduced body weight on hepatic gene expression as follows: 1) WP30, weight-paired rats with CH group on PND30, corresponds to animals that were sacrificed on PND24 and 2) WP, weight-paired rats with CH group on PND80, which were sacrificed on PND53. For the generation of adult hypothyroid rats (TX), 0.05% MMI was added to the drinking water for 3 weeks <a href="#pone.0037386-HenriquezHernandez1" rid="pone.0037386-HenriquezHernandez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868616">[23]</a> starting at PND60 until sacrifice at PND80. Thus, two additional groups were created as follows: 1) adult TX rats without CH (TX/&#x02212;CH) and 2) adult TX rats with CH (TX/+CH). A schematic diagram of this experimental model is shown in Supplementary <a href="#pone.0037386.s001" rid="pone.0037386.s001" class=" supplementary-material">File S1</a>. The presence of hypothyroidism was corroborated by monitoring the body weight and serum levels of T3 and T4. During the last week of life, TX rats were either injected with T3 (20 &#x000b5;g/kg b.w.) as a single daily ip injection or with GH (0.4 mg/kg/day) divided into two daily sb injections that were carried out at 08:00 h and 20:00 h. T3 was dissolved in a minimum volume of 0.01 N NaOH and was brought up to the appropriate concentration with sterile saline. In parallel, TX animals received equivalent amounts (0.20 ml) of the vehicle alone (VEH). Twenty-four hours (in the case of T3) or twelve hours (in the case of GH) after the last injection, animals were sacrificed by exsanguination after pentothal anesthesia. Twelve hours before the rats were sacrificed, the diet was removed from the cages to minimize the effect of food. Serum samples were collected and stored at &#x02212;80&#x000b0;C until analysis. Portions of the liver were snap frozen in liquid nitrogen and stored at &#x02212;80&#x000b0;C until being processed for mRNA or biochemical analysis.</p></div><div id="s2c" class="sec"><h3>Growth and food intake analysis</h3><p id="__p8" class="p p-first-last">Body weights, tail lengths, and food intake were measured once a week for all animals. The measurement of tail length was used for monitoring growth <a href="#pone.0037386-de1" rid="pone.0037386-de1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868598">[31]</a>, <a href="#pone.0037386-Lee1" rid="pone.0037386-Lee1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868613">[32]</a>, <a href="#pone.0037386-Marino1" rid="pone.0037386-Marino1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868647">[33]</a>, <a href="#pone.0037386-Finkielstain1" rid="pone.0037386-Finkielstain1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868588">[34]</a>
<kbd>. </kbd>The percentages of weight rate (WR) or tail rate (TR) were calculated by the following formulas: WR&#x0200a;=&#x0200a;[(W (g) (new) &#x02013; W (g) (old)/W (g) (old)]*100 or TR&#x0200a;=&#x0200a;[(T (cm) (new) &#x02013; T (cm) (old)/T (cm) (old)]*100, respectively. Food consumption was estimated by subtracting the amount of food left on the grid from initial food weight. Food spilled on the floor of the cage was not weighed, but spillage was minimal because the diet was supplied as pellets. Mother and pups were housed in the same cage until weaning on PND30. Then, weaned pups were housed in pairs to control for food efficiency. The weekly caloric intake was calculated on the basis of food consumption x caloric value of the diet (2900 kcal/g). Feed efficiency (FE), which denotes the body weight increase per gram of food consumed or the ability to transform calories consumed into body weight <a href="#pone.0037386-Meyer1" rid="pone.0037386-Meyer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868643">[35]</a>, was calculated by the following formula: mean body weight gain (g)/total caloric intake. The weights of the liver, heart, and kidneys as well as the organ weight/total body weight ratios were also calculated on PND30 and PND80.</p></div><div id="s2d" class="sec"><h3>Serum IGF-I, TSH, T3, and T4 analysis</h3><p id="__p9" class="p p-first-last">The <strong>s</strong>erum levels of IGF-I (Quantikine; R&#x00026;D Systems) and TSH (Gentaur Molecular Products, Belgium) were determined by using rat immunoassays and following the manufacturers' recommendations. All of the samples were assayed together, and each sample was assayed in duplicate. The serum free T4 and T3 concentrations (ng/dl) were measured in duplicate by an enzyme immunoassay (Access Immunoassay Systems, Beckman Coulter, Inc., USA) with detection limits of 0.60 ng/dl and 88 ng/dl, respectively.</p></div><div id="s2e" class="sec"><h3>Serum lipid analysis</h3><p id="__p10" class="p p-first-last">Lipoproteins were separated essentially as previously described <a href="#pone.0037386-Parini1" rid="pone.0037386-Parini1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868597">[36]</a> using a Superose&#x000ae;-12 PC 3.2/30 column (Pharmacia Biotech, Uppsala, Sweden). Serum from each animal (2.5 &#x000b5;L) was separated for cholesterol and triglycerides, which were subsequently assayed on-line. Total cholesterol and triglycerides were assayed using cholesterol and triglyceride colorimetric enzymatic kits (Roche/Hitachi Diagnostic GmbH, Mannheim, Germany). The serum triglyceride value for each animal was normalized to the respective glycerol content. Absorbance was continuously measured at 500 nm, and data were collected every 10 s using EZ Chrom&#x02122; software (Scientific Software, San Ramon, CA).</p></div><div id="s2f" class="sec"><h3>Hepatic lipid analysis</h3><p id="__p11" class="p p-first-last">Frozen liver aliquots were used for lipid extraction <a href="#pone.0037386-Folch1" rid="pone.0037386-Folch1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868632">[37]</a>, and aliquots of lipid extracts were quantified after separation by one-dimensional TLC <a href="#pone.0037386-Ruiz1" rid="pone.0037386-Ruiz1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868579">[38]</a> and image analysis using the G5-700 Bioimage TLC scanner (Bio-Rad, CA). The spots were quantified as integrated optical density against an internal standard of cholesteryl formate and against calibration curves of the different lipid standards.</p></div><div id="s2g" class="sec"><h3>RNA isolation, cDNA microarray, probe preparation, and hybridization</h3><p id="__p12" class="p p-first-last">Total RNA was isolated by the homogenization of frozen liver as previously described <a href="#pone.0037386-HenriquezHernandez1" rid="pone.0037386-HenriquezHernandez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868601">[23]</a>. All samples were treated with RNase-free DNase (Promega, Madison, WI). The RNA yields were measured by UV absorbance, and the quality of total RNA was analyzed with a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). A microarray containing 27,000 rat 70-mer oligo probe sets, which was produced at the KTH Microarray Center (<a href="http://www.biotech.kth.se" ref="reftype=extlink&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">www.biotech.kth.se</a>), was used to evaluate the effects of CH on liver gene expression in adulthood. Five micrograms of high-quality total RNA from liver was reversed-transcribed, labeled, and hybridized according to the manufacturer's protocol (Pronto&#x02122; Plus System; Promega). After 16 h of hybridization, the slides were scanned using a GenePix Microarray Scanner (Axon Instruments, CA). Four independent hybridizations were performed to compare individual animals from the CH group (n&#x0200a;=&#x0200a;4) with those from the INTACT group (n&#x0200a;=&#x0200a;4) on PND80 for a total of four analyses.</p></div><div id="s2h" class="sec"><h3>Data processing and analysis</h3><p id="__p13" class="p p-first-last">Image analysis was performed using GenePix Pro 6.0 software (Axon Instruments, Union City, CA) as previously described <a href="#pone.0037386-HenriquezHernandez1" rid="pone.0037386-HenriquezHernandez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868595">[23]</a>. The LOWESS (Locally Weighted Scatter Plot Smoother) method in the SMA (Statistics for Microarray) <a href="#pone.0037386-Quackenbush1" rid="pone.0037386-Quackenbush1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868661">[39]</a> package (<a href="http://www.bioconductor.org" ref="reftype=extlink&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">www.bioconductor.org</a>) was used to normalize the raw data. The probe sets not present in at least three of the four chips were considered as meaningless and therefore were eliminated to reduce data complexity. Identification of differentially expressed genes was performed using the SAM (Significance Analysis for Microarrays) statistical technique <a href="#pone.0037386-Tusher1" rid="pone.0037386-Tusher1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868559">[40]</a>. A <em>q</em> value was assigned to each of the detectable genes in the array. This value is similar to a <em>P</em>-value and measure the lowest false discovery rate (FDR) at which the differential expression of a gene is considered significant. A minimal FDR of 0.05 was assigned for each gene. An additional selection requirement was added to this statistically based criterion, which was based on the absolute changes in the gene expression ratios. A value of 1.5 (50%) (log<sub>2</sub> ratio CH/INTACT&#x02265;|0.58|) was chosen to describe ratios as up- or downregulated. Functional classifications (Gene Ontology) and pathway analysis (KEGG) of differentially expressed genes that were affected by CH were performed by using the web-based tool DAVID <a href="#pone.0037386-Huangda1" rid="pone.0037386-Huangda1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868654">[41]</a>. All microarray data are MIAME compliant, and the raw data have been deposited in Gene Expression Omnibus database (<a href="http://www.ncbi.nlm.nih.gov/geo" ref="reftype=extlink&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">www.ncbi.nlm.nih.gov/geo</a>).</p></div><div id="s2i" class="sec"><h3>Gene expression analysis by real-time quantitative PCR (qPCR)</h3><p id="__p14" class="p p-first-last">The mRNA expression levels of genes were measured using qPCR as previously described <a href="#pone.0037386-HenriquezHernandez1" rid="pone.0037386-HenriquezHernandez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868641">[23]</a>. Briefly, 2 &#x000b5;g of total RNA was treated with RNase-free DNase I (Promega) and reverse transcribed by using an iScriptTM kit (Bio-Rad Laboratories). Two microliters of cDNA served as a template in a 20-&#x000b5;l qPCR reaction mix containing the primers and SYBR Green PCR Master mix (Diagenode, Belgium). Quantification of the gene expression was performed with an ABI PRISM&#x000ae; 7000 SD PCR System. A dissociation protocol was performed to assess the specificity of the primers and the uniformity of the PCR generated products. Exon-specific primers were designed by the Primer 3 program <a href="#pone.0037386-Rozen1" rid="pone.0037386-Rozen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868638">[42]</a> and are listed in Supplementary <a href="#pone.0037386.s001" rid="pone.0037386.s001" class=" supplementary-material">File S2</a>. The level of individual mRNAs measured by qPCR was normalized to the level of the housekeeping genes cyclophilin and ribosomal 28S by using the Pfaffl method <a href="#pone.0037386-Pfaffl1" rid="pone.0037386-Pfaffl1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868618">[43]</a>. For graphing purposes, the relative expression levels were scaled such that the expression of the INTACT control group equalled one.</p></div><div id="s2j" class="sec sec-last"><h3>Statistical analysis</h3><p id="__p15" class="p p-first-last">The data are expressed as the means &#x000b1; SD. The significance of differences between the groups was tested by either a two-tailed Student's <em>t</em> test or a one-way ANOVA, which was followed by post hoc comparisons of the group means according to the GraphPad Prism 5 program (GraphPad Software, San Diego, CA). A two-tailed Student's <em>t</em> test was performed on PND80 for body weight and tail length to assess the effect of CH and the completeness of recovery. Statistical significance was reported if <em>P</em>&#x0003c;0.05 was achieved.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Results</h2><div id="s3a" class="sec sec-first"><h3>Neonatal hypothyroidism delays body growth development and is followed by catch-up growth</h3><p id="__p16" class="p p-first">There were no significant MMI treatment-related differences in dam's body weights and intake of feed and drinking water throughout gestation (data not shown). There were no apparent MMI treatment-related effects on the offspring's body weights over the 3&#x02013;4 PND. As expected <a href="#pone.0037386-NantoSalonen1" rid="pone.0037386-NantoSalonen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868611">[4]</a>, <a href="#pone.0037386-MorrealedeEscobar1" rid="pone.0037386-MorrealedeEscobar1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868653">[26]</a>, the INTACT pups on the tap water recorded normal size and growth during development, while defects due to the MMI treatment in CH rats were evident by a reduction in body weight (Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>; panel A) and tail length (Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>; panel B) from the second week of life. Upon weaning on PND30, biochemical hypothyroidism was shown, and significantly low circulating T3 (pg/ml) (9.93&#x000b1;0.66 <em>vs.</em> 7.80&#x000b1;0.83; <em>P</em>&#x0200a;=&#x0200a;0.0008) and elevated TSH (ng/ml) (2.73&#x000b1;2.04 <em>vs</em>. 6.72&#x000b1;2.5; <em>P</em>&#x0200a;=&#x0200a;0.012) levels were found in CH rats in comparison with the age-matched INTACT group. In addition, circulating IGF-I (ng/ml) levels were reduced by 55% in the CH group (716.33&#x000b1;132.62 vs. 323.25&#x000b1;45.97; <em>P</em>&#x0200a;=&#x0200a;0.0001). Furthermore, the mRNA levels of ME (0.15&#x000b1;0.10 vs. 1&#x000b1;0.04; <em>P</em>&#x0200a;=&#x0200a;0.0001) and Spot14 (0.30&#x000b1;0.10 vs. 1&#x000b1;0.02; <em>P</em>&#x0200a;=&#x0200a;0.0001), two genes positively regulated by TH <a href="#pone.0037386-Yen1" rid="pone.0037386-Yen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868648">[1]</a>, were also markedly reduced in the CH group. In liver, the fetal expression pattern of high IGFBP-2 levels was replaced by the adult pattern of low levels of IGFBP-2 only in the presence of normal levels of TH during rat development <a href="#pone.0037386-NantoSalonen1" rid="pone.0037386-NantoSalonen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868602">[4]</a>. CH rats expressed higher levels of IGFBP2 mRNA in comparison with the INTACT or WP control rats (Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>; panel C). Collectively, these data support the presence of neonatal hypothyroidism on PND30.</p><p id="__p17" class="p">Once the MMI treatment was discontinued on PND30, the animals gradually recovered and significant catch-up (defined as growth rate that is greater than normal for age after a period of growth inhibition) <a href="#pone.0037386-Boersma1" rid="pone.0037386-Boersma1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868568">[44]</a> occurred in terms of body weight (Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>; panel D) and tail length (Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>; panel E). It was evident in all hypothyroid rats that, <strong>w</strong>hen MMI was withdrawn, they rapidly began to increase their growth rates in a compensatory manner to make up for their deficits and to catch up with the normal age-matched control rats. These results suggest that, in agreement with what has been previously shown <a href="#pone.0037386-Peake1" rid="pone.0037386-Peake1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868564">[45]</a>, <a href="#pone.0037386-Cooper1" rid="pone.0037386-Cooper1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868651">[46]</a>, <a href="#pone.0037386-Calvo1" rid="pone.0037386-Calvo1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868644">[47]</a>, <a href="#pone.0037386-Knipper1" rid="pone.0037386-Knipper1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868567">[48]</a>, the plasma levels of THs were rapidly recovered (i.e., within 2&#x02013;4 days after discontinuation of MMI treatment). Interestingly, the feed efficiency was significantly increased in CH rats (Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>; panel F). On PND80, a statistically significant difference remained in body mass (g) (430&#x000b1;29.69 vs. 333&#x000b1;29.72; <em>P</em>&#x0200a;=&#x0200a;0.002) (Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>; panel A), tail length (cm) (21.9&#x000b1;0.62 vs. 20.3&#x000b1;0.73; <em>P</em>&#x0200a;=&#x0200a;0.002) (Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>; panel B), and circulating IGF-I levels (ng/ml) (1541.24&#x000b1;76.74 vs. 1305.15&#x000b1;126.27; <em>P</em>&#x0200a;=&#x0200a;0.003) between INTACT and CH groups, respectively, indicating that growth was incomplete. Importantly, at the time of sacrifice, the growth rate, measured as a percentage of body weight gain (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g001" rid-ob="ob-pone-0037386-g001" co-legend-rid="lgnd_pone-0037386-g001"><span>Fig. 1A</span></a>) or tail length gain (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g001" rid-ob="ob-pone-0037386-g001" co-legend-rid="lgnd_pone-0037386-g001"><span>Fig. 1B</span></a>), was similar between the two groups, which suggests that the CH animals may have finished a period of rapid catch-up growth. The weights of the liver and kidneys at the end of the study (i.e., PND80), corrected by total body weight, were similar in the CH rats in comparison with age-matched INTACT rats (data not shown), which also suggests that the compensatory growth of organs in relation to body weight was achieved. Furthermore, on PND80, the serum levels of T3 (ng/dl) (45.15&#x000b1;5.77 vs. 47.52&#x000b1;3.17), T4 (ng/dl) (1.94&#x000b1;0.27 vs. 1.52&#x000b1;0.18), total cholesterol (mM) (1.54&#x000b1;0.15 vs. 1.65&#x000b1;0.21), and triglycerides (mM) (1.20&#x000b1;0.23 vs. 1.18&#x000b1;0.28) in the CH group did not differ from the INTACT animals. Subtle changes in hepatic IGF-I (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g002" rid-ob="ob-pone-0037386-g002" co-legend-rid="lgnd_pone-0037386-g002"><span>Fig. 2A</span></a>) and IGFBP-3 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g002" rid-ob="ob-pone-0037386-g002" co-legend-rid="lgnd_pone-0037386-g002"><span>Fig. 2B</span></a>) mRNA levels together with increased levels of IGFBP-2 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g002" rid-ob="ob-pone-0037386-g002" co-legend-rid="lgnd_pone-0037386-g002"><span>Fig. 2C</span></a>), a gene that is a marker of delayed development or hypothyroidism in rats <a href="#pone.0037386-NantoSalonen1" rid="pone.0037386-NantoSalonen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868574">[4]</a>, <a href="#pone.0037386-Lee2" rid="pone.0037386-Lee2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868573">[49]</a>, were also shown on PND80. Because the expression of IGFBP-2 mRNA levels was similar in the CH and WP groups, this result indicates that the overexpression is a consequence of delayed growth and low body weight rather than a long-lasting consequence of CH. However, in comparison with age-matched INTACT rats, several genes remained unaltered or were upregulated in CH rats whereas they were significantly downregulated in the WP control group (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3</span></a>&#x02013;<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span></span></a>
<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -0em;">5).</span></span><span>5</span></a>). Collectively, these results suggest that the induction of neonatal hypothyroidism alters the normal development of the liver gene expression program, which may impact GH-related liver functions.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0037386-g001" co-legend-rid="lgnd_pone-0037386-g001"><a href="/pmc/articles/PMC3354003/figure/pone-0037386-g001/" target="figure" rid-figpopup="pone-0037386-g001" rid-ob="ob-pone-0037386-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662069570816" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3354003_pone.0037386.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0037386.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3354003/bin/pone.0037386.g001.jpg" /></a></div><div id="largeobj_idm140662069570816" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/figure/pone-0037386-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0037386-g001"><div><a class="figpopup" href="/pmc/articles/PMC3354003/figure/pone-0037386-g001/" target="figure" rid-figpopup="pone-0037386-g001" rid-ob="ob-pone-0037386-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of neonatal hypothyroidism on body growth development.</strong><p id="__p18">Percentages of body weight rate (A) or tail length rate (B) were measured at 7-d intervals as described in <a href="#s2" rid="s2" class=" sec">Material and Methods</a>. Results are expressed as mean &#x000b1; SD from six individual animals in each group. **, <em>P</em>&#x0003c;0.01, ***, <em>P</em>&#x0003c;0.001 for comparison with INTACT group.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0037386-g002" co-legend-rid="lgnd_pone-0037386-g002"><a href="/pmc/articles/PMC3354003/figure/pone-0037386-g002/" target="figure" rid-figpopup="pone-0037386-g002" rid-ob="ob-pone-0037386-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662075699568" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3354003_pone.0037386.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0037386.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3354003/bin/pone.0037386.g002.jpg" /></a></div><div id="largeobj_idm140662075699568" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/figure/pone-0037386-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0037386-g002"><div><a class="figpopup" href="/pmc/articles/PMC3354003/figure/pone-0037386-g002/" target="figure" rid-figpopup="pone-0037386-g002" rid-ob="ob-pone-0037386-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of neonatal hypothyroidism on mRNA expression levels of IGF-I and IGFBP genes in adult rat liver.</strong><p id="__p19">On PND80, the hepatic mRNA levels of IGF-I (A), IGFBP3 (B), and IGFBP2 (C) were measured by qPCR in rats exposed to neonatal hypothyroidism (CH), age-matched (INTACT) or weight-paired (WP) control groups. The mean mRNA expression level of each gene in the INTACT group is defined as 1, with all other expression values reported relative to this level. Bars represent mean &#x000b1; SD from at least six individual animals. ***, <em>P</em>&#x0003c;0.001 for comparison with INTACT group. <strong>+++</strong>, <em>P</em>&#x0003c;0.001 for comparison with WP group.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662071296176" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3354003_pone.0037386.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0037386.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3354003/bin/pone.0037386.g003.jpg" /></a></div><div id="largeobj_idm140662071296176" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0037386-g003"><div><a class="figpopup" href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of neonatal hypothyroidism on mRNA expression levels of SOCS/CIS and male predominant genes in adult rat liver.</strong><p id="__p20">On PND80, the hepatic mRNA levels of SOCS2 (A), CIS (B), SOCS3 (C), PIAS3 (D), SOCS5 (E), CYP2C11 (F), CYP2C13 (G) and CYP2C7 (H) were measured by qPCR in rats exposed to neonatal hypothyroidism (CH), age-matched (INTACT) or weight-paired (WP) control groups. The mean mRNA expression level of each gene in the INTACT group is defined as 1, with all other expression values reported relative to this level. Bars represent mean &#x000b1; SD from at least six individual animals. ***, <em>P</em>&#x0003c;0.001 for comparison with INTACT group. <strong>++</strong>, <em>P</em>&#x0003c;0.01; <strong>+++</strong>, <em>P</em>&#x0003c;0.001 for comparison with WP group.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662113288928" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3354003_pone.0037386.g004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0037386.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3354003/bin/pone.0037386.g004.jpg" /></a></div><div id="largeobj_idm140662113288928" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0037386-g004"><div><a class="figpopup" href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of neonatal hypothyroidism on mRNA expression levels of genes related with lipid metabolism in adult rat liver.</strong><p id="__p21">On PND80, the hepatic mRNA levels of PPAR&#x003b1; (A), CPT1 (B), ME (C), SREBP1c (D), ACC1 (E), FAS (F), CYP4FI (G), AOX (H), and L-FABP (I) were measured by qPCR in CH, age-matched INTACT, or weight-paired (WP) control groups. The mean mRNA expression level of each gene in the INTACT group is defined as 1, with all other expression values reported relative to this level. Bars represent mean &#x000b1; SD from at least five individual animals. *, <em>P</em>&#x0003c;0.05; ***, <em>P</em>&#x0003c;0.001 for comparison with INTACT group. <strong>++</strong>, <em>P</em>&#x0003c;0.01; <strong>+++</strong>, <em>P</em>&#x0003c;0.001 for comparison with WP group.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662075501280" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3354003_pone.0037386.g005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0037386.g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3354003/bin/pone.0037386.g005.jpg" /></a></div><div id="largeobj_idm140662075501280" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0037386-g005"><div><a class="figpopup" href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of congenital hypothyroidism on mRNA expression levels of INSIG-1, SREBP2, LXR, and genes involved in lipid transport in adult rat liver.</strong><p id="__p22">On PND80, the hepatic mRNA levels of INSIG1 (A), SREBP2 (B), LDLR (C), CD36 (D), ABCA (E), LXR (F), HLipase (G), HMGCoAS (H), and HMHCoAR (I) were measured by qPCR in CH, age-matched INTACT or weight-paired (WP) control groups. The mean mRNA expression level of each gene in the INTACT group is defined as 1, with all other expression values reported relative to this level. Bars represent mean &#x000b1; SD from at least five individual animals. *, <em>P</em>&#x0003c;0.05; ***, <em>P</em>&#x0003c;0.001 for comparison with INTACT group. <strong>+</strong>, <em>P</em>&#x0003c;0.05; <strong>++</strong>, <em>P</em>&#x0003c;0.01; <strong>+++</strong>, <em>P</em>&#x0003c;0.001 for comparison with WP group.</p></div></div></div></div><div id="s3b" class="sec"><h3>Influence of neonatal hypothyroidism on Growth Hormone-regulated genes</h3><p id="__p23" class="p p-first-last">An altered growth rate or a long-lasting influence on somatotropic axis (i.e., GH, liver and IGF-I) could be related to the effects of CH on the hepatic GH signaling system <a href="#pone.0037386-RicoBautista1" rid="pone.0037386-RicoBautista1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868674">[50]</a>, <a href="#pone.0037386-Ahmed1" rid="pone.0037386-Ahmed1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868624">[51]</a>. To test this hypothesis, we next analyzed the mRNA expression levels of the GH-regulated genes CIS and SOCS2, which act as negative regulators of GH signaling. On PND30, the CIS mRNA expression level was significantly upregulated (<em>P</em>&#x0003c;0.001) in CH rats (9.93&#x000b1;4.45) in comparison with the INTACT (1&#x000b1;0.03) and WP30 (0.87&#x000b1;0.67) groups, whereas SOCS2 remained unchanged. However, on PND80, SOCS2 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3A</span></a>) and CIS (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3B</span></a>) were upregulated whereas SOCS3 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3C</span></a>) and additional GH-independent negative regulators of STAT-mediated signaling such as PIAS3 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3D</span></a>) and SOCS5 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3E</span></a>) were downregulated. We next explored whether the increased hepatic expression of SOCS2 and CIS mRNA levels in adult rats exposed to CH was associated with a negative regulation of GH target genes or instead reflected enhanced GH signaling. CYP2C11 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3F</span></a>) and CYP2C13 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3G</span></a>), two biomarkers of the male gene expression pattern in rats that are under GH control <a href="#pone.0037386-Waxman1" rid="pone.0037386-Waxman1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868578">[52]</a>, were overexpressed in CH in comparison with the INTACT or WP groups, whereas the female-predominant CYP2C7 gene was downregulated (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g003" rid-ob="ob-pone-0037386-g003" co-legend-rid="lgnd_pone-0037386-g003"><span>Fig. 3H</span></a>). These results show that CH influences the mRNA regulation of GH target genes in the adult liver. The absence of major effects on IGF-I expression suggests the presence of complex transcriptional mechanisms <em>in vivo</em> that deserve further research.</p></div><div id="s3c" class="sec"><h3>Neonatal hypothyroidism influences the liver gene expression program in adulthood, and it is associated with decreased levels of intrahepatic lipids</h3><p id="__p24" class="p p-first">To better understand the influence of transient neonatal hypothyroidism on adult liver physiology, we next carried out an exploratory analysis of the global gene expression changes in the CH group on PND80 compared to INTACT rats by using DNA microarrays. We identified the set of genes that were differentially regulated in the CH group and analyzed the biological processes represented based on gene annotations in the Gene Ontology (<a href="http://www.ncbi.nlm.nih.gov/geo" ref="reftype=extlink&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">www.ncbi.nlm.nih.gov/geo</a>) and the KEGG pathway databases <a href="#pone.0037386-Huangda1" rid="pone.0037386-Huangda1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868655">[41]</a>. These exploratory analyses indicated that genes with altered expression in the CH group were functionally related to lipid metabolism (<em>P</em>&#x0200a;=&#x0200a;0.0001). In particular, &#x0201c;PPAR&#x003b1;&#x0201d; was the signaling pathway (KEGG) most represented among the CH regulated genes, suggesting alterations in hepatic lipid metabolism even in the absence of overt changes in circulating cholesterol and triglyceride levels (see below). Accordingly, our study showed that the hepatic content (mg/g of tissue; n&#x0200a;=&#x0200a;6) of triglycerides (3.91&#x000b1;0.6 vs. 1.49&#x000b1;0.18; <em>P</em>&#x0003c;0.001), cholesteryl esters (0.30&#x000b1;0.02 vs. 0.21&#x000b1;0.04; <em>P</em>&#x0003c;0.001), free fatty acids (FFA) (0.18&#x000b1;0.03 vs. 0.13&#x000b1;0.004; <em>P</em>&#x0003c;0.05), and phospholipids (57.8&#x000b1;4.1 vs. 48.7&#x000b1;8.8; <em>P</em>&#x0003c;0.05) were significantly reduced in CH in comparison with INTACT rats. However, no changes in the free cholesterol (2.4&#x000b1;0.2 vs. 2.1&#x000b1;0.3) content (mg/g of tissue) were observed.</p><p id="__p25">In order to determine whether the decreased hepatic content of lipids in CH rats was due to increased lipid catabolism, decreased lipid synthesis, increased lipid excretion, or some combination of these mechanisms, we analyzed the hepatic mRNA levels for proteins mediating these processes by using qPCR. First, <a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Figure 4A</span></a> shows that the mRNA levels of PPAR&#x003b1;, a master regulator of &#x003b2;-oxidation, were upregulated in the CH group. Similar results were observed when measuring the mRNA expression of carnitine palmitoyl transferase-1 (CPT1) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4B</span></a>), a PPAR&#x003b1; target gene coding for a protein that is important for transferring fatty acyl-CoAs into the mitochondria for &#x003b2;-oxidation <a href="#pone.0037386-Rakhshandehroo1" rid="pone.0037386-Rakhshandehroo1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868663">[53]</a>. In contrast, PPAR&#x003b1; (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4A</span></a>) and CPT1 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4B</span></a>) were downregulated in the WP group. Phosphoenolpyruvate carboxykinase (PEPCK), a rate-limiting gene in gluconeogenesis, remained unaltered in the CH group, whereas it was significantly reduced in the WP control group (data not shown).</p><p id="__p26" class="p">ME is a TH-regulated enzyme that converts malate into pyruvate to generate NADPH which is destined for lipogenesis and other biosynthetic processes <a href="#pone.0037386-Castelein1" rid="pone.0037386-Castelein1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868664">[54]</a>. We found that the ME mRNA levels (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4C</span></a>) were upregulated in the CH rats on PND80, but the levels of SREBP1c (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4D</span></a>), a master regulator of lipogenesis, were significantly downregulated. The SREBP1c target genes, acetyl-CoA carboxylase-1 (ACC1) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4E</span></a>), the product of which is the rate-limiting metabolite for fatty acid biosynthesis and inhibits CPT-1 <a href="#pone.0037386-Tong1" rid="pone.0037386-Tong1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868687">[55]</a>, and fatty acid synthase (FAS) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4F</span></a>), as well as several genes known to be regulated by PPAR&#x003b1; such as CYP4F1 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4G</span></a>), palmitoyl-CoA oxidase (AOX) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4H</span></a>) and liver fatty acid-binding protein (L-FABP) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g004" rid-ob="ob-pone-0037386-g004" co-legend-rid="lgnd_pone-0037386-g004"><span>Fig. 4I</span></a>), were not affected in the CH group whereas they were significantly reduced in the WP control group. The steady-state mRNA level for insulin-induced gene 1 (INSIG-1) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5A</span></a>), an SREBP target, was also reduced in the CH rats. Overall, our data do not support the activation of a lipogenic program in the CH rats. Interestingly, the hepatic mRNA expression levels of SREBP2 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5B</span></a>) and its target gene LDLR (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5C</span></a>), the product of which is involved in hepatic VLDL uptake, were 2&#x02013;3-fold lower in the CH rats compared with the INTACT rats. Similar results were obtained for the gene expression levels of CD36 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5D</span></a>), which is involved in the uptake of FFA and microsomal triglyceride transfer protein (MTTP) (data not shown), which is involved in triglycerides assembly, indicating that diminished uptake of fatty acids may contribute to the reduced hepatic TG levels observed in the CH rats <a href="#pone.0037386-Horton1" rid="pone.0037386-Horton1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868589">[56]</a>. ABCA1 (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5E</span></a>), a transporter responsible for cholesterol efflux, was also reduced whereas LXR (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5F</span></a>), hepatic lipase (HL) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5G</span></a>), and HMGCoA-S (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5H</span></a>) remained unchanged. HMGCoA-R (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g005" rid-ob="ob-pone-0037386-g005" co-legend-rid="lgnd_pone-0037386-g005"><span>Fig. 5I</span></a>) was upregulated in CH group. In contrast, the mRNA expression levels of LXR, HL, HMGCoA-R, and HMGCoA-S were significantly downregulated in the WP group. In addition, the mRNA expression levels of enzymes responsible for the catabolism of cholesterol such as 7&#x003b1;-hydroxylase (CYP7A1) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g006" rid-ob="ob-pone-0037386-g006" co-legend-rid="lgnd_pone-0037386-g006"><span>Fig. 6A</span></a>), which is the rate-limiting enzyme in hepatic bile acid synthesis, sterol 27 hydroxylase (CYP27A1) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g006" rid-ob="ob-pone-0037386-g006" co-legend-rid="lgnd_pone-0037386-g006"><span>Fig. 6B</span></a>), and 12&#x003b1;-hydroxylase (CYP8B1) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g006" rid-ob="ob-pone-0037386-g006" co-legend-rid="lgnd_pone-0037386-g006"><span>Fig. 6C</span></a>), which is an enzyme involved in cholic acid synthesis <a href="#pone.0037386-Vlahcevic1" rid="pone.0037386-Vlahcevic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868575">[57]</a>, <a href="#pone.0037386-Hunt1" rid="pone.0037386-Hunt1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868677">[58]</a>, were downregulated in the CH and in the WP groups in comparison with the INTACT rats. Farnesoid X receptor (FXR) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g006" rid-ob="ob-pone-0037386-g006" co-legend-rid="lgnd_pone-0037386-g006"><span>Fig. 6D</span></a>), a receptor for bile acids <a href="#pone.0037386-Vlahcevic1" rid="pone.0037386-Vlahcevic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868570">[57]</a>, was also downregulated in the CH rats. In contrast, small heterodimer partner (SHP) (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g006/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g006" rid-ob="ob-pone-0037386-g006" co-legend-rid="lgnd_pone-0037386-g006"><span>Fig. 6E</span></a>), a gene induced by FXR, remained unchanged, which suggests that there is low activity of the bile acid-FXR signaling pathway. Collectively, these data indicate that a transient neonatal exposure to hypothyroidism causes changes in lipid metabolism in the liver and, particularly, in the cholesterol metabolism pathway that persist long after removal of the original insult, in animals that are euthyroid and exhibit similar growth rate as intact rats.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0037386-g006" co-legend-rid="lgnd_pone-0037386-g006"><a href="/pmc/articles/PMC3354003/figure/pone-0037386-g006/" target="figure" rid-figpopup="pone-0037386-g006" rid-ob="ob-pone-0037386-g006"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662073886592" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3354003_pone.0037386.g006.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0037386.g006.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3354003/bin/pone.0037386.g006.jpg" /></a></div><div id="largeobj_idm140662073886592" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/figure/pone-0037386-g006/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0037386-g006"><div><a class="figpopup" href="/pmc/articles/PMC3354003/figure/pone-0037386-g006/" target="figure" rid-figpopup="pone-0037386-g006" rid-ob="ob-pone-0037386-g006">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of congenital hypothyroidism on mRNA expression levels of genes involved in bile acid synthesis in adult rat liver.</strong><p id="__p27">On PND80, the hepatic mRNA levels of CYP7A1 (A), CYP27A1 (B), CYP8B1 (C), FXR (D), and SHP (E) were measured by qPCR in CH, age-matched INTACT or weight-paired (WP) control groups. The mean mRNA expression level of each gene in the INTACT group is defined as 1, with all other expression values reported relative to this level. Bars represent mean &#x000b1; SD from at least five individual animals. **, <em>P</em>&#x0003c;0.01; ***, <em>P</em>&#x0003c;0.001 for comparison with INTACT group. <strong>+++</strong>, <em>P</em>&#x0003c;0.001 for comparison with WP group.</p></div></div></div></div><div id="s3d" class="sec sec-last"><h3>Neonatal hypothyroidism influences the hepatic response to hormone replacement in adulthood</h3><p id="__p28" class="p p-first">Although CH rats were euthyroid on PND80 (i.e., the time when the comparative gene expression was performed), they showed changes in liver gene expression in comparison with age-matched INTACT rats (see above) that involved previously characterized T3 (e.g., ME) or GH (e.g.SOCS2, CIS, IGF-I, CYP2C11, INSIG-1, and IGFBP-3) regulated genes. Thus, we hypothesized that the different transcriptional profile in the CH group could be explained by altered tissue responsiveness to T3 and/or GH, two hormones that are drastically reduced by hypothyroidism <a href="#pone.0037386-NantoSalonen2" rid="pone.0037386-NantoSalonen2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868599">[6]</a>, <a href="#pone.0037386-Mullis1" rid="pone.0037386-Mullis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868683">[7]</a>, <a href="#pone.0037386-Rasmussen1" rid="pone.0037386-Rasmussen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868650">[8]</a>. To test this hypothesis, we developed a second burst of hypothyroidism (TX) in adulthood, which was followed by hormone replacement as described in &#x0201c;<a href="#s2" rid="s2" class=" sec">Materials and Methods</a>&#x0201d;. As expected, in vehicle or GH-treated TX rats, the serum levels of T3 were significantly reduced whereas the levels of T3-replaced animals did not differ from the INTACT control rats (data not shown). We showed a decrease in the total body weights of TX rats (<em>P</em>&#x0003c;0.001) and little subsequent weight gain in the TX/&#x02212;CH (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7A</span></a>) and TX/+CH rats (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7B</span></a>). Independent of CH status, we showed the following: 1) the development of TX increased the circulating cholesterol levels and decreased the triglyceride serum levels (<a href="/pmc/articles/PMC3354003/table/pone-0037386-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0037386-t001" rid-ob="ob-pone-0037386-t001" co-legend-rid=""><span>Table 1</span></a>), which were mainly due to an increase of LDL and HDL cholesterol and a decrease of VLDL (data not shown), respectively, while the T3 hormone replacement restored the circulating cholesterol; 2) T3 and GH treatments increased the body weight gain in TX rats but it was unable to normalize it completely (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7A,B</span></a>); and 3) T3 and GH treatments increased the hepatic level of IGF-I mRNA and, unlike T3, GH was capable of fully restoring the level to normal (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7C</span></a>). However, the development of TX in the CH group (i.e., TX/+CH) resulted in a greater than 3-fold reduction of circulating FFAs, which was not observed in the TX/&#x02212;CH group, and the T3 replacement restored it (<a href="/pmc/articles/PMC3354003/table/pone-0037386-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0037386-t001" rid-ob="ob-pone-0037386-t001" co-legend-rid=""><span>Table 1</span></a>). Next, we evaluated the effects of hormone replacement on the hepatic lipid content (<a href="/pmc/articles/PMC3354003/table/pone-0037386-t002/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0037386-t002" rid-ob="ob-pone-0037386-t002" co-legend-rid=""><span>Table 2</span></a>). Independent of the CH status, T3 treatment restored hepatic cholesterol levels. However, in comparison with INTACT, GH increased the hepatic cholesteryl esters in the TH/&#x02212;CH but not in the TH/+CH group. Additionally, to evaluate whether an altered response to the T3 treatment was associated with an altered transcriptional response, we measured the changes in gene expression of T3-regulated genes such as ME and FAS. The effect of GH was also measured. As expected, the development of TX in TX/&#x02212;CH rats significantly reduced the mRNA levels of ME (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7D</span></a>) and FAS (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7E</span></a>). However, the development of TX in the TX/+CH group did not decrease ME (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7D</span></a>) and, surprisingly, increased the mRNA levels of FAS up to 5-fold (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7E</span></a>). Furthermore, T3 replacement in the TX/&#x02212;CH rats increased the mRNA expression levels of ME and FAS by 12- and 3-fold, respectively. However, T3 replacement in the TX/+CH rats increased the expression of ME up to 30-fold which suggested an altered tissue sensitivity to T3 replacement. Taken together, these findings suggest that the tissue responsiveness to TH was altered in rats previously exposed to CH. At this point, we can only speculate about the molecular mechanisms that could support our hypothesis. However, because altered hepatic levels of TR might support a different metabolic response to TH in the liver <a href="#pone.0037386-Sjogren1" rid="pone.0037386-Sjogren1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868678">[12]</a>, <a href="#pone.0037386-Vujovic1" rid="pone.0037386-Vujovic1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868594">[14]</a>, <a href="#pone.0037386-Pelletier1" rid="pone.0037386-Pelletier1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868684">[59]</a>, we made an exploratory analysis of the expression of TR&#x003b2;/TR&#x003b1; mRNA in the CH rats. The hepatic mRNA level of TR&#x003b1; (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7F</span></a>) was significantly reduced in the CH group whereas the TR&#x003b2; mRNA (<a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><span>Fig. 7G</span></a>) remained unaltered. However, the mRNA expression levels of TR&#x003b1; and TR&#x003b2; were downregulated in the WP group, which suggests that TR&#x003b1;, unlike TR&#x003b2; was influenced by CH.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0037386-g007" co-legend-rid="lgnd_pone-0037386-g007"><a href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662113343072" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3354003_pone.0037386.g007.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0037386.g007.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3354003/bin/pone.0037386.g007.jpg" /></a></div><div id="largeobj_idm140662113343072" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0037386-g007"><div><a class="figpopup" href="/pmc/articles/PMC3354003/figure/pone-0037386-g007/" target="figure" rid-figpopup="pone-0037386-g007" rid-ob="ob-pone-0037386-g007">Figure 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Effects of hormonal replacement on body weight and hepatic mRNA expression levels of IGF-I, ME, and FAS in adult hypothyroid rats without or with transient exposure to neonatal hypothyroidism.</strong><p id="__p29">Four groups were studied: 1) age-matched rats (INTACT); 2) adult rats with neonatal hypothyroidism (CH); 3) hypothyroid adult rats without CH (TX/&#x02212;CH); and 4) hypothyroid adult rats with CH (TX/+CH). During the last week of life, TX/&#x02212;CH and TX/+CH groups were treated with either T3 or GH daily. Control animals were injected with saline (VEH). Body weight (A and B) as well as hepatic mRNA levels of IGF-I (C), ME (D) and FAS (E) were measured. The hepatic mRNA levels of TR&#x003b1; (F) and TR&#x003b2; (G) were also measured by qPCR in CH, age-matched INTACT or weight-paired (WP) control groups. The mean mRNA expression level of each gene in the INTACT group is defined as 1, with all other expression values reported relative to this level. Results represent mean &#x000b1; SD from at least six individual rats *, <em>P</em>&#x0003c;0.05; **, <em>P</em>&#x0003c;0.01; ***, <em>P</em>&#x0003c;0.001 for comparison with INTACT group (panel A) and for comparison with CH group (panel B); +, <em>P</em>&#x0003c;0.05; ++, <em>P</em>&#x0003c;0.01; +++, <em>P</em>&#x0003c;0.001 for comparison with vehicle-treated TX group. <strong>&#x0005e;&#x00302;&#x00302;</strong>, <em>P</em>&#x0003c;0.001 for comparison with WP group.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0037386-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Serum lipids from PND80 male rats at baseline (INTACT), without (&#x02212;CH) or with (+CH) transient neonatal exposure to MMI, during thyroid hormone deprivation (vehicle) and hormonal replacement.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662149712416" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Cholesterol (mM)</td><td align="left" rowspan="1" colspan="1">Triglycerides (mM)</td><td align="left" rowspan="1" colspan="1">FFA (mM)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">INTACT</td><td align="left" rowspan="1" colspan="1">1.38&#x000b1;0.13</td><td align="left" rowspan="1" colspan="1">1.59&#x000b1;0.65</td><td align="left" rowspan="1" colspan="1">0.69&#x000b1;0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">TX/&#x02212;CH</td><td colspan="3" align="left" rowspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Vehicle</td><td align="left" rowspan="1" colspan="1">3.01&#x000b1;0.13<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.62&#x000b1;0.17<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">0.58&#x000b1;0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">T3</td><td align="left" rowspan="1" colspan="1">1.69&#x000b1;0.16+++</td><td align="left" rowspan="1" colspan="1">0.67&#x000b1;0.20<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">0.75&#x000b1;0.30</td></tr><tr><td align="left" rowspan="1" colspan="1">GH</td><td align="left" rowspan="1" colspan="1">2.77&#x000b1;0.39<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.44&#x000b1;0.13<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.28&#x000b1;0.04<sup>***</sup>; ++</td></tr><tr><td align="left" rowspan="1" colspan="1">TX/+CH</td><td colspan="3" align="left" rowspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Vehicle</td><td align="left" rowspan="1" colspan="1">3.15&#x000b1;0.31<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.72&#x000b1;0.05<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">0.24&#x000b1;0.07<sup>***</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">T3</td><td align="left" rowspan="1" colspan="1">1.52&#x000b1;0.18+++</td><td align="left" rowspan="1" colspan="1">0.61&#x000b1;0.17<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">0.59&#x000b1;0.13+++</td></tr><tr><td align="left" rowspan="1" colspan="1">GH</td><td align="left" rowspan="1" colspan="1">2.70&#x000b1;0.57<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.66&#x000b1;0.20<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">0.25&#x000b1;0.06<sup>***</sup>
</td></tr></tbody></table></div><div id="largeobj_idm140662149712416" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/table/pone-0037386-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><sup></sup>
<strong>INTACT and CH animals were exposed to MMI at PND60 as described in <a href="#s2" rid="s2" class=" sec">Materials and Methods</a>. From day 73, animals were injected daily with vehicle, T3 or GH for 7 d. The animals were sacrificed on PND80 and serum lipids were measured. Results are expressed as mean &#x000b1; SD (n&#x0200a;=&#x0200a;6). Statistical comparison was performed for treated animals using INTACT animals or vehicle as controls.</strong>
</div><div id="nt102"><sup>**</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.01;</strong>
</div><div id="nt103"><sup>***</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.001 for comparison with INTACT rats;</strong>
</div><div id="nt104"><sup>++</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.01;</strong>
</div><div id="nt105"><sup>+++</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.001 for comparison with vehicle.</strong>
</div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0037386-t002"><h3>Table 2</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Hepatic lipids in liver from PND80 male rats at baseline (INTACT), without (&#x02212;CH) or with (+CH) transient neonatal exposure to MMI, during thyroid hormone deprivation (vehicle) and hormonal replacement.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140662075375328" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">Free cholesterol (mg/g of tissue)</td><td align="left" rowspan="1" colspan="1">Triglycerides (mg/g of tissue)</td><td align="left" rowspan="1" colspan="1">Cholesteryl esters (mg/g of tissue)</td><td align="left" rowspan="1" colspan="1">Fatty acids (mg/g of tissue)</td><td align="left" rowspan="1" colspan="1">Phospholipids (mg/g of tissue)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">INTACT</td><td align="left" rowspan="1" colspan="1">2.4&#x000b1;0.2</td><td align="left" rowspan="1" colspan="1">3.9&#x000b1;0.6</td><td align="left" rowspan="1" colspan="1">0.30&#x000b1;0.02</td><td align="left" rowspan="1" colspan="1">0.18&#x000b1;0.03</td><td align="left" rowspan="1" colspan="1">57.8&#x000b1;4.1</td></tr><tr><td align="left" rowspan="1" colspan="1">TX/&#x02212;CH</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Vehicle</td><td align="left" rowspan="1" colspan="1">1.9&#x000b1;0.1<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">2.1&#x000b1;0.2<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.37&#x000b1;0.04<sup>*</sup>
</td><td align="left" rowspan="1" colspan="1">0.15&#x000b1;0.01<sup>*</sup>
</td><td align="left" rowspan="1" colspan="1">51.6&#x000b1;3.4<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">T3</td><td align="left" rowspan="1" colspan="1">2.3&#x000b1;0.3++</td><td align="left" rowspan="1" colspan="1">1.5&#x000b1;0.2<sup>***</sup>;+</td><td align="left" rowspan="1" colspan="1">0.33&#x000b1;0.05</td><td align="left" rowspan="1" colspan="1">0.14&#x000b1;0.01<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">58.2&#x000b1;5.9</td></tr><tr><td align="left" rowspan="1" colspan="1">GH</td><td align="left" rowspan="1" colspan="1">2.1&#x000b1;0.2<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">1.4&#x000b1;0.1<sup>***</sup>;++</td><td align="left" rowspan="1" colspan="1">0.54&#x000b1;0.15 <sup>***</sup>;++</td><td align="left" rowspan="1" colspan="1">0.12&#x000b1;0.01<sup>***</sup>;+</td><td align="left" rowspan="1" colspan="1">50.7&#x000b1;4.9<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">TX/+CH</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Vehicle</td><td align="left" rowspan="1" colspan="1">1.9&#x000b1;0.2<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">2.1&#x000b1;0.3<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.21&#x000b1;0.02<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">0.13&#x000b1;0.01<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">48.9&#x000b1;4.8<sup>*</sup>
</td></tr><tr><td align="left" rowspan="1" colspan="1">T3</td><td align="left" rowspan="1" colspan="1">2.0&#x000b1;0.3<sup>*</sup>
</td><td align="left" rowspan="1" colspan="1">1.7&#x000b1;0.4<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.34&#x000b1;0.09++</td><td align="left" rowspan="1" colspan="1">0.13&#x000b1;0.01<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">54.6&#x000b1;5.5</td></tr><tr><td align="left" rowspan="1" colspan="1">GH</td><td align="left" rowspan="1" colspan="1">1.7&#x000b1;0.2<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">1.6&#x000b1;0.3<sup>***</sup>
</td><td align="left" rowspan="1" colspan="1">0.31&#x000b1;0.07++</td><td align="left" rowspan="1" colspan="1">0.12&#x000b1;0.01<sup>**</sup>
</td><td align="left" rowspan="1" colspan="1">43.8&#x000b1;2.3<sup>***</sup>;+</td></tr></tbody></table></div><div id="largeobj_idm140662075375328" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3354003/table/pone-0037386-t002/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt106"><sup></sup>
<strong>INTACT and CH animals were exposed to MMI at PND60 as described in <a href="#s2" rid="s2" class=" sec">Materials and Methods</a>. From day 73, animals were injected daily with vehicle, T3 or GH for 7 d. The animals were sacrificed on PND80 and hepatic lipids were measured. Results are expressed as mean &#x000b1; SD (n&#x0200a;=&#x0200a;6). Statistical comparison was performed for treated animals using INTACT animals or vehicle as controls.</strong>
</div><div id="nt107"><sup>*</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.05;</strong>
</div><div id="nt108"><sup>**</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.01;</strong>
</div><div id="nt109"><sup>***</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.001 for comparison with INTACT rats;</strong>
</div><div id="nt110"><sup>+</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.05;</strong>
</div><div id="nt111"><sup>++</sup>
<strong>, </strong>
<strong><em>P</em></strong>
<strong>&#x0003c;0.01 for comparison with vehicle.</strong>
</div></div></div></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p id="__p41" class="p p-first">The THs are essential for development, growth, and metabolism <a href="#pone.0037386-Yen1" rid="pone.0037386-Yen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868675">[1]</a>, <a href="#pone.0037386-DeFelice1" rid="pone.0037386-DeFelice1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868671">[2]</a>, <a href="#pone.0037386-LeRoith1" rid="pone.0037386-LeRoith1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868686">[3]</a>. The present study shows that transient neonatal hypothyroidism in male rats gave rise to endocrine alterations that not only affected postnatal growth but also influenced hepatic physiology and responsiveness to THs replacement in adulthood.</p><p id="__p42">Growth-inhibiting conditions exist during development in association with malnutrition, glucocorticoid excess, systemic diseases, GH-IGF-I deficiency, or hypothyroidism <a href="#pone.0037386-Boersma1" rid="pone.0037386-Boersma1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868658">[44]</a>, <a href="#pone.0037386-Lui1" rid="pone.0037386-Lui1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868637">[60]</a>, <a href="#pone.0037386-Saenger1" rid="pone.0037386-Saenger1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868596">[61]</a>. In this work, several biomarkers of neonatal hypothyroidism (i.e., decreased circulating THs and hepatic mRNA expression levels of ME and Spot14) and high expression of IGFBP-2 were associated with decreased circulating IGF-I and a delayed somatic growth rate on PND30. Furthermore, when the growth-inhibiting condition (i.e., MMI) was removed, somatic growth rate (weight and tail lenght gain) and food efficiency increased in CH rats, which is a phenomenon known as catch-up growth <a href="#pone.0037386-Boersma1" rid="pone.0037386-Boersma1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868572">[44]</a>, <a href="#pone.0037386-Lui1" rid="pone.0037386-Lui1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868673">[60]</a>. By PND80, however, this effect had subsided, and somatic growth rate (see body weight gain and tail length gain in Supplementary <a href="#pone.0037386.s003" rid="pone.0037386.s003" class=" supplementary-material">File S3</a>) in CH animals was similar to age-matched INTACT controls. Alternatively, higher food efficiency remained in euthyroid CH group on PND80 along with significance differences in total body weight and size in comparison with INTACT group, which suggests, in agreement with previously reported data <a href="#pone.0037386-Davenport1" rid="pone.0037386-Davenport1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868592">[62]</a>, a higher but less efficient rate of metabolism (i.e., a reduced ability to transform calories consumed into total body weight and size) in rats previously exposed to CH. The CH rats on PND80 also showed increased mRNA levels of several GH target genes (i.e., IGF-I, SOCS-2, CIS, CYP2C11, CYP2C13) suggesting that the increased hepatic GH activity observed in these animals was possibly associated with catch-up growth. In contrast, other well-known GH target genes in female rats such as CYP2C7 and CD36 were downregulated in CH group. This apparent paradox could be explained by sexually dimorphic pattern of gene expression in rat liver <a href="#pone.0037386-Vidal1" rid="pone.0037386-Vidal1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868639">[63]</a>, <a href="#pone.0037386-Waxman2" rid="pone.0037386-Waxman2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868617">[64]</a>. The downregulation of female-predominant genes (e.g., CYP2C7 and CD36) concomitant with the induction of male-predominant genes (e.g., CYP2C11 and CYP2C13) suggests that a male pattern of gene expression was enhanced in CH rat liver.</p><p id="__p43">In the current study, we show that transient CH is associated with changes in SOCS-2 and CIS expression, which are key negative regulators of GH-dependent somatic growth <em>in vivo</em>
<a href="#pone.0037386-Ahmed1" rid="pone.0037386-Ahmed1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868666">[51]</a>, <a href="#pone.0037386-FloresMorales2" rid="pone.0037386-FloresMorales2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868670">[65]</a>. GH resistance can be shown in rat models of sepsis and uremia and in small rats for gestational age (SGA) without catch-up growth. This was associated with an increased expression of SOCS-2 and CIS and impaired JAK/STAT signaling <a href="#pone.0037386-Schaefer1" rid="pone.0037386-Schaefer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868667">[66]</a>, <a href="#pone.0037386-Chen1" rid="pone.0037386-Chen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868635">[67]</a>, <a href="#pone.0037386-Huang1" rid="pone.0037386-Huang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868628">[68]</a>. In our model, however, catch-up growth was associated with the overexpression of SOCS-2 and CIS in adult CH rats. Whether the overexpression of SOCS and CIS is associated with delayed growth development and catch-up growth in CH rats requires further research.</p><p id="__p44">Growth-inhibiting conditions during fetal-neonatal period of life may influence lipid metabolism in adulthood <a href="#pone.0037386-Fraser1" rid="pone.0037386-Fraser1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868584">[69]</a>, <a href="#pone.0037386-Shahkhalili1" rid="pone.0037386-Shahkhalili1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868614">[70]</a>, <a href="#pone.0037386-Chen2" rid="pone.0037386-Chen2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868676">[71]</a>, <a href="#pone.0037386-Morrison1" rid="pone.0037386-Morrison1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868672">[72]</a>. Human and rats, who do show catch-up of somatic growth and increased feed efficiency after withdrawal of growth-inhibiting condition (e.g., SGA or caloric restriction), have higher risk of fat in the liver and increased adiposity in adulthood <a href="#pone.0037386-Fraser1" rid="pone.0037386-Fraser1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868585">[69]</a>, <a href="#pone.0037386-Shahkhalili1" rid="pone.0037386-Shahkhalili1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868633">[70]</a>, <a href="#pone.0037386-Chen2" rid="pone.0037386-Chen2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868629">[71]</a>, <a href="#pone.0037386-Morrison1" rid="pone.0037386-Morrison1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868631">[72]</a>. Now, we show that somatic growth inhibition by neonatal hypothyroidism influences hepatic lipid metabolism in adulthood. CH rats showed a concomitant upregulation of PPAR&#x003b1; and CPT1, a gene related to fatty acid catabolism<kbd>. </kbd>Furthermore, adult CH rats showed a downregulation of CD36, which is involved in fatty acid uptake and a well-known PPAR&#x003b1; target gene, along with the reduced transcription of genes involved in cholesterol uptake (LDLR), cellular sterol efflux (ABCA), triglyceride assembly (MTTP), bile acid synthesis (CYP8B1, CYP7A1 and CYP27A1), and lipogenesis (SREBP1c) <a href="#pone.0037386-Desvergne1" rid="pone.0037386-Desvergne1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868605">[73]</a>
<kbd>. </kbd>These data indicate that CH significantly influenced lipid metabolism in adulthood and, most likely, contributed to the diminished hepatic levels of triglycerides, cholesteryl esters, and FFA. Conversely, because expression levels of several lipid genes in CH adult group were altered in similar direction to that detected in WP group, our data could be explained, in part, as a consequence of delayed growth <a href="#pone.0037386-Marino1" rid="pone.0037386-Marino1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868608">[33]</a>, <a href="#pone.0037386-Finkielstain1" rid="pone.0037386-Finkielstain1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868566">[34]</a>. Furthermore, a reduced content of hepatic lipids in CH group could be caused by prolonged catch-up growth which might cause an increased lipid catabolism in growing animals (i.e., CH group) in comparison with those that have completed their body growth (i.e., INTACT). To determine whether some of these changes caused by CH are life-long adaptations, similar analysis would need to be performed in older animals <a href="#pone.0037386-Marino1" rid="pone.0037386-Marino1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868607">[33]</a>, <a href="#pone.0037386-Finkielstain1" rid="pone.0037386-Finkielstain1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868649">[34]</a>. Furthermore, the reduced content of hepatic lipids in CH group could be caused by prolonged catch-up growth which might cause increased lipid catabolism in growing animals (i.e., CH group) in comparison with those that have completed their body growth (i.e., INTACT). However, several reports have suggested that catch-up growth is likely associated with increased level of hepatic lipids and adiposity <a href="#pone.0037386-Morrison1" rid="pone.0037386-Morrison1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868562">[72]</a>, which would not be in agreement with this explanation. Additionally, despite all of the changes observed in liver, the levels of circulating lipids (triglycerides and cholesterol) and lipoproteins (data not shown) were similar to those in the INTACT aged-matched littermates, which suggest that CH rats were able to maintain lipid homeostasis and support the increased energy demands imposed by an accelerated growth rate. This is apparently achieved by redistributing lipids from the liver towards peripheral tissues rather than through active hepatic lipogenesis, which is an energy-consuming process that would compete with peripheral energy needs.</p><p id="__p45">In this study, we show that transient neonatal hypothyroidism influences transcriptional program in adult liver. Despite being euthyroid, adult CH animal showed a modified transcriptional profile in liver in comparison with age-matched INTACT rats, which might be explained by altered tissue responsiveness to T3 and/or GH, two hormones that are drastically reduced by hypothyroidism <a href="#pone.0037386-NantoSalonen2" rid="pone.0037386-NantoSalonen2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868625">[6]</a>, <a href="#pone.0037386-Mullis1" rid="pone.0037386-Mullis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868668">[7]</a>, <a href="#pone.0037386-Rasmussen1" rid="pone.0037386-Rasmussen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868582">[8]</a>. However, independent of CH status, several of the responses to hypothyroidism and hormone replacement were similar. As expected, development of TX increased circulating cholesterol levels and decreased the serum triglyceride levels, while T3 hormone replacement restored circulating cholesterol level. Additionally, T3 and GH treatments increased the body weight gain and hepatic levels of IGF-I mRNA. At first glance, these results suggested that the CH rats, after suffering a biological insult (i.e., a second burst of hypothyroidism in adulthood), showed a biological response similar to age-matched INTACT rats. However, several of the responses to TX or hormone replacement suggested an altered lipid metabolism in the CH rats. First, a significant reduction of circulating FFAs by TX in TX/+CH group but not in TX/&#x02212;CH group, an effect that was restored by T3 replacement. Second, GH-increased hepatic cholesterol esterification occurred in the TH/&#x02212;CH animals but not in the TH/+CH animals. Third, GH treatment reduced serum VLDL fraction in the TX/&#x02212;CH but not in the TX/+CH rats (data not shown). We did not observe major alterations in hepatic reactivity to GH in terms of lipid changes which suggests that the capacity of GH treatment to reduce serum triglyceride levels in TX/&#x02212;CH rats, but not in TX/+CH rats, is most likely due to altered GH activity in extrahepatic tissues, such as fat and muscle <a href="#pone.0037386-LeRoith1" rid="pone.0037386-LeRoith1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868603">[3]</a>. Finally, hepatic concentrations of lipids in T3-treated TX/+CH rats did not differ significantly from TX/&#x02212;CH group, which suggested that the homeostatic capacity of CH tissue in response to T3 was not dramatically affected. However, this is in contrast to the enhanced ME expression in the TX/+CH group in response to the T3 treatment. Increased ME mRNA expression did not seem to be a general response to T3 replacement because SREBP1c and 2 showed a less pronounced change (data not shown). ME is directly regulated by the binding of TR to a TRE in the promoter of the ME gene <a href="#pone.0037386-Petty1" rid="pone.0037386-Petty1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868689">[74]</a>. Our measurement of mRNA levels for TR receptors in liver showed unaltered expression of the major isoform TR&#x003b2; and reduced levels of TR&#x003b1;, making it unlikely that changes in ME expression can be attributed to altered TR content. Noticeably, the ME regulatory region also contains binding sites for PBX1 and 2 <a href="#pone.0037386-Wang1" rid="pone.0037386-Wang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868563">[75]</a>, CEBP&#x003b1; <a href="#pone.0037386-Yin1" rid="pone.0037386-Yin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868583">[76]</a>, and an E-box <a href="#pone.0037386-Wang2" rid="pone.0037386-Wang2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868606">[77]</a> that can modulate the response to T3. At this point, we cannot exclude the possibility that CH effects on these transcription factors and other nuclear co-regulators influence ME expression but additional experiments are needed to test this hypothesis. Likewise, a clearer mechanistic explanation for the metabolic changes observed in the CH rats would require, among others measures, the analysis of fat and muscle metabolism.</p><p id="__p46">Androgens may influence the hepatic response to CH. It is well known that neonatal hypothyroidism results in increased circulating levels of testosterone in male rats, which is secondary to increased testis size <a href="#pone.0037386-Kirby1" rid="pone.0037386-Kirby1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868591">[29]</a>. We also observed two-fold higher serum testosterone levels in the CH rats compared to the age-matched adult INTACT rats (data not shown). Although the liver is not considered to be a primary target of testosterone action, androgens maintain specific male pattern of pituitary GH secretion and actions on liver <a href="#pone.0037386-Ho1" rid="pone.0037386-Ho1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868610">[78]</a>, and it has been shown that specific deletion of androgen receptor (AR) in liver of male animals causes hepatic insulin resistance with decreased fatty acid &#x003b2;-oxidation and steatosis <a href="#pone.0037386-Lin1" rid="pone.0037386-Lin1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868657">[79]</a>, which implicates the hepatic AR as a positive factor in maintaining physiological control of glucose and lipid homeostasis. Alternatively, in prostate, a well-known target tissue of androgen action, testosterone has lipogenic effects, such as inducing the expression of FAS <a href="#pone.0037386-Heemers1" rid="pone.0037386-Heemers1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868682">[80]</a>. Therefore, we cannot exclude the possibility that some of the transcriptional effects detected in the liver of the CH rats (e.g., increased CYP2C11, CYP2C13, and PPAR&#x003b1;) were secondary to increased levels of circulating testosterone.</p><p id="__p47" class="p p-last">In summary, our findings support the hypothesis that TH deprivation during neonatal period of life causes long-lasting influence on the liver transcriptome and provokes an altered responsiveness to biological insult in adulthood. Several findings that cannot be explained by the lower body weight in CH rats, compared to WP, include genes regulated by GH (e.g., IGF-I, CIS, CYP2C11, and CYP2C13) and genes involved in hepatic lipid metabolism (e.g., PPAR&#x003b1;, CPT1, ME, ACC1, FAS, CYP4F1, AOX, L-FABP, LXR, HMGCoA-S, and HMGCoA-R). Being clinically relevant, the changes observed in the transcriptional responses to T3 highlight the possibility that CH influences tissue reactivity to thyromimetic drugs in adulthood <a href="#pone.0037386-Larsen1" rid="pone.0037386-Larsen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868586">[81]</a>. Interestingly, thyroid-disrupting compounds, which can cause neonatal hypothyroidism, include a wide range of chemicals from naturally occurring compounds, pharmaceuticals, and a number of xenobiotics <a href="#pone.0037386-BruckerDavis1" rid="pone.0037386-BruckerDavis1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_677868640">[82]</a>. The long-lasting influence of growth-inhibiting conditions on hepatic metabolism is intriguing and warrants further study to explore whether the alterations observed in this study cause metabolic disruptions or chronic diseases.</p></div><div id="s5" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="s5title">Supporting Information</h2><!--/article/body/sec/--><div class="sec suppmat" id="pone.0037386.s001"><h4>File S1</h4><p id="__p48">
<strong>Schematic diagram of rat model used to study the effects of congenital hypothyroidism on adult rat liver.</strong> Congenital-neonatal hypothyroid male rats (CH) were produced by 0.02%-MMI administration in the drinking water of pregnant rats (GD12) until weaning at PND30. For generation of adult hypothyroid rats (TX), 0.05% MMI was added to the drinking water for 3 weeks starting at PND58. Four groups were studied: 1) euthyroid age-matched rats (INTACT); 2) CH; 3) TX rats without CH (TX/&#x02212;CH); and 4) TX rats with CH (TX/+CH). During the last week of life, TX/&#x02212;CH and TX/+CH groups were treated with either T3 or GH daily for 7 days as described in <a href="#s2" rid="s2" class=" sec">Materials and Methods</a>. Control animals were injected with saline. Each group included six individual animals.</p><p id="__p49">(TIF)</p><div class="sup-box half_rhythm"><a href="/pmc/articles/PMC3354003/bin/pone.0037386.s001.tif">Click here for additional data file.</a><sup>(159K, tif)</sup></div></div><div class="sec suppmat" id="pone.0037386.s002"><h4>File S2</h4><p id="__p51">
<strong>Gene names and primer sequences (5&#x02032;- 3&#x02032;) used for real-time PCR.</strong>
</p><p id="__p52">(TIF)</p><div class="sup-box half_rhythm"><a href="/pmc/articles/PMC3354003/bin/pone.0037386.s002.tif">Click here for additional data file.</a><sup>(1.2M, tif)</sup></div></div><div class="sec suppmat" id="pone.0037386.s003"><h4>File S3</h4><p id="__p54">
<strong>Effects of neonatal hypothyroidism on body growth development.</strong> Body weight (A) and tail length (B) were measured at 7-d intervals. On PND30, the hepatic mRNA levels of IGFBP2 (C) were measured by qPCR in rats exposed to neonatal hypothyroidism (CH), age-matched (INTACT) or weight-paired (WP30) control groups. Body weight gain (D), tail growth gain (E) and food efficiency (F) were measured at 7-d intervals as described in <a href="#s2" rid="s2" class=" sec">Material and Methods</a>. Results are expressed as mean &#x000b1; SD from six individual animals in each group. **, <em>P</em>&#x0003c;0.01, ***, <em>P</em>&#x0003c;0.001 for comparison with INTACT group. <strong>+++</strong>, <em>P</em>&#x0003c;0.001 for comparison with WP group.</p><p id="__p55">(TIF)</p><div class="sup-box half_rhythm"><a href="/pmc/articles/PMC3354003/bin/pone.0037386.s003.tif">Click here for additional data file.</a><sup>(303K, tif)</sup></div></div></div><div id="idm140662110368816" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140662110368816title">Acknowledgments</h2><div class="sec"><p id="__p57">The excellent technical assistance of M. Morante and C. J. Mateos-D&#x000ed;az is greatly appreciated. R.S-F was recipient of pre-doctoral fellowships from the MCYT (SAF2003-02117) and ACIISI-FSE (SE-10/13) and M.M-G and L.H-H were recipients from University of Las Palmas de GC and MEC (AP2001-3499), respectively.</p></div></div><div id="idm140662148235808" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140662148235808title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140662109253792"><p id="__p58" class="p p-first-last"><strong>Competing Interests: </strong>The authors have read the journal's policy and have the following conflicts: AF-M is supported by the Novo Nordisk Foundation. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.</p></p><p class="fn sec" id="idm140662147895056"><p id="__p59" class="p p-first-last"><strong>Funding: </strong>This work was supported by grants-in-aid to LF-P from the Spanish Ministry of Science and Innovation with the funding of European Regional Development Fund-European Social Fund (SAF2003-02117 and SAF2006-07824) and Canary Islands Government (ACIISI; PI2007/033). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></p></div></div><div id="idm140662111042160" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140662111042160title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0037386-Yen1">1. <span class="element-citation">Yen PM, Feng X, Flamant F, Chen Y, Walker RL, et al.  Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knockout mice. <span><span class="ref-journal">EMBO Rep. </span>2003;<span class="ref-vol">4</span>:581–587.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1319202/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12776178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-DeFelice1">2. <span class="element-citation">De Felice M, Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. <span><span class="ref-journal">Endocr Rev. </span>2004;<span class="ref-vol">25</span>:722–746.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15466939" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-LeRoith1">3. <span class="element-citation">LeRoith D, Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. <span><span class="ref-journal">Nat Clin Pract Endocrinol Metab. </span>2007;<span class="ref-vol">3</span>:302–310.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17315038" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-NantoSalonen1">4. <span class="element-citation">Nanto-Salonen K, Glasscock GF, Rosenfeld RG. The effects of thyroid hormone on insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) expression in the neonatal rat: prolonged high expression of IGFBP-2 in methimazole-induced congenital hypothyroidism. <span><span class="ref-journal">Endocrinology. </span>1991;<span class="ref-vol">129</span>:2563–2570.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/1718729" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Samuels1">5. <span class="element-citation">Samuels MH, Wierman ME, Wang C, Ridgway EC. The effect of altered thyroid status on pituitary hormone messenger ribonucleic acid concentrations in the rat. <span><span class="ref-journal">Endocrinology. </span>1989;<span class="ref-vol">124</span>:2277–2282.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/2707156" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-NantoSalonen2">6. <span class="element-citation">Nanto-Salonen K, Muller HL, Hoffman AR, Vu TH, Rosenfeld RG. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated. <span><span class="ref-journal">Endocrinology. </span>1993;<span class="ref-vol">132</span>:781–788.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/7678799" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Mullis1">7. <span class="element-citation">Mullis PE, Eble A, Marti U, Burgi U, Postel-Vinay MC. Regulation of human growth hormone receptor gene transcription by triiodothyronine (T3). <span><span class="ref-journal">Mol Cell Endocrinol. </span>1999;<span class="ref-vol">147</span>:17–25.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10195688" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Rasmussen1">8. <span class="element-citation">Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, et al.  The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. <span><span class="ref-journal">Metabolism. </span>1994;<span class="ref-vol">43</span>:315–319.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/7511202" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Moreno1">9. <span class="element-citation">Moreno B, Rodriguez-Manzaneque JC, Perez-Castillo A, Santos A. Thyroid hormone controls the expression of insulin-like growth factor I receptor gene at different levels in lung and heart of developing and adult rats. <span><span class="ref-journal">Endocrinology. </span>1997;<span class="ref-vol">138</span>:1194–1203.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9048627" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Hoogerbrugge1">10. <span class="element-citation">Hoogerbrugge N, Jansen H, Staels B, Kloet LT, Birkenhager JC. Growth hormone normalizes low-density lipoprotein receptor gene expression in hypothyroid rats. <span><span class="ref-journal">Metabolism. </span>1996;<span class="ref-vol">45</span>:680–685.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/8637440" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Lazar1">11. <span class="element-citation">Lazar MA, Willson TM. Sweet dreams for LXR. <span><span class="ref-journal">Cell Metab. </span>2007;<span class="ref-vol">5</span>:159–161.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17339022" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Sjogren1">12. <span class="element-citation">Sjogren M, Alkemade A, Mittag J, Nordstrom K, Katz A, et al.  Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1. <span><span class="ref-journal">Embo J. </span>2007;<span class="ref-vol">26</span>:4535–4545.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2063481/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17932484" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Klieverik1">13. <span class="element-citation">Klieverik LP, Janssen SF, van Riel A, Foppen E, Bisschop PH, et al.  Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>:5966–5971.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2660059/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19321430" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Vujovic1">14. <span class="element-citation">Vujovic M, Nordstrom K, Gauthier K, Flamant F, Visser TJ, et al.  Interference of a mutant thyroid hormone receptor alpha1 with hepatic glucose metabolism. <span><span class="ref-journal">Endocrinology. </span>2009;<span class="ref-vol">150</span>:2940–2947.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19282388" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Angelin1">15. <span class="element-citation">Angelin B, Rudling M. Lipid lowering with thyroid hormone and thyromimetics. <span><span class="ref-journal">Curr Opin Lipidol. </span>2010;<span class="ref-vol">21</span>:499–506.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20935564" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Lopez1">16. <span class="element-citation">Lopez D, Abisambra Socarras JF, Bedi M, Ness GC. Activation of the hepatic LDL receptor promoter by thyroid hormone. <span><span class="ref-journal">Biochim Biophys Acta. </span>2007;<span class="ref-vol">1771</span>:1216–1225.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17572141" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Gullberg1">17. <span class="element-citation">Gullberg H, Rudling M, Forrest D, Angelin B, Vennstrom B. Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterol. <span><span class="ref-journal">Mol Endocrinol. </span>2000;<span class="ref-vol">14</span>:1739–1749.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11075809" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Ness1">18. <span class="element-citation">Ness GC, Lopez D. Transcriptional regulation of rat hepatic low-density lipoprotein receptor and cholesterol 7 alpha hydroxylase by thyroid hormone. <span><span class="ref-journal">Arch Biochem Biophys. </span>1995;<span class="ref-vol">323</span>:404–408.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/7487105" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Fang1">19. <span class="element-citation">Fang X, Hillgartner FB. Cell-specific regulation of transcription of the malic enzyme gene: characterization of cis-acting elements that modulate nuclear T3 receptor activity. <span><span class="ref-journal">Arch Biochem Biophys. </span>1998;<span class="ref-vol">349</span>:138–152.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9439592" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-GonzalezManchon1">20. <span class="element-citation">Gonzalez-Manchon C, Butta N, Ferrer M, Ayuso MS, Parrilla R. Molecular cloning and functional characterization of the human cytosolic malic enzyme promoter: thyroid hormone responsiveness. <span><span class="ref-journal">DNA Cell Biol. </span>1997;<span class="ref-vol">16</span>:533–544.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9174159" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Xiong1">21. <span class="element-citation">Xiong S, Chirala SS, Hsu MH, Wakil SJ. Identification of thyroid hormone response elements in the human fatty acid synthase promoter. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1998;<span class="ref-vol">95</span>:12260–12265.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC22819/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9770474" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-FloresMorales1">22. <span class="element-citation">Flores-Morales A, Gullberg H, Fernandez L, Stahlberg N, Lee NH, et al.  Patterns of liver gene expression governed by TRbeta. <span><span class="ref-journal">Mol Endocrinol. </span>2002;<span class="ref-vol">16</span>:1257–1268.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12040013" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-HenriquezHernandez1">23. <span class="element-citation">Henriquez-Hernandez LA, Flores-Morales A, Santana-Farre R, Axelson M, Nilsson P, et al.  Role of pituitary hormones on 17alpha-ethinylestradiol-induced cholestasis in rat. <span><span class="ref-journal">J Pharmacol Exp Ther. </span>2007;<span class="ref-vol">320</span>:695–705.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17108234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Hashimoto1">24. <span class="element-citation">Hashimoto K, Yamada M, Matsumoto S, Monden T, Satoh T, et al.  Mouse sterol response element binding protein-1c gene expression is negatively regulated by thyroid hormone. <span><span class="ref-journal">Endocrinology. </span>2006;<span class="ref-vol">147</span>:4292–4302.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16794015" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Rodd1">25. <span class="element-citation">Rodd C, Schwartz HL, Strait KA, Oppenheimer JH. Ontogeny of hepatic nuclear triiodothyronine receptor isoforms in the rat. <span><span class="ref-journal">Endocrinology. </span>1992;<span class="ref-vol">131</span>:2559–2564.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/1446599" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-MorrealedeEscobar1">26. <span class="element-citation">Morreale de Escobar G, Obregon MJ, Ruiz de Ona C, Escobar del Rey F. Transfer of thyroxine from the mother to the rat fetus near term: effects on brain 3,5,3&#x02032;-triiodothyronine deficiency. <span><span class="ref-journal">Endocrinology. </span>1988;<span class="ref-vol">122</span>:1521–1531.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/3345725" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Oppenheimer1">27. <span class="element-citation">Oppenheimer JH, Schwartz HL. Molecular basis of thyroid hormone-dependent brain development. <span><span class="ref-journal">Endocr Rev. </span>1997;<span class="ref-vol">18</span>:462–475.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9267760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Holness1">28. <span class="element-citation">Holness MJ, Sugden MC. Epigenetic regulation of metabolism in children born small for gestational age. <span><span class="ref-journal">Curr Opin Clin Nutr Metab Care. </span>2006;<span class="ref-vol">9</span>:482–488.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16778581" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Kirby1">29. <span class="element-citation">Kirby JD, Arambepola N, Porkka-Heiskanen T, Kirby YK, Rhoads ML, et al.  Neonatal hypothyroidism permanently alters follicle-stimulating hormone and luteinizing hormone production in the male rat. <span><span class="ref-journal">Endocrinology. </span>1997;<span class="ref-vol">138</span>:2713–2721.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9202208" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Cooke1">30. <span class="element-citation">Cooke PS, Hess RA, Porcelli J, Meisami E. Increased sperm production in adult rats after transient neonatal hypothyroidism. <span><span class="ref-journal">Endocrinology. </span>1991;<span class="ref-vol">129</span>:244–248.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/2055187" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-de1">31. <span class="element-citation">de GC. Tail growth in the thyroxine-treated hypophysectomized rat as a sensitive criterion for growth hormone activity. <span><span class="ref-journal">Acta Endocrinol (Copenh) </span>1963;<span class="ref-vol">42</span>:423–431.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/13950707" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Lee1">32. <span class="element-citation">Lee MM, Chu PC, Chan HC. Effects of cold on the skeletal growth of albino rats. <span><span class="ref-journal">Am J Anat. </span>1969;<span class="ref-vol">124</span>:239–249.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/5774652" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Marino1">33. <span class="element-citation">Marino R, Hegde A, Barnes KM, Schrier L, Emons JA, et al.  Catch-up growth after hypothyroidism is caused by delayed growth plate senescence. <span><span class="ref-journal">Endocrinology. </span>2008;<span class="ref-vol">149</span>:1820–1828.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2276705/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18174286" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Finkielstain1">34. <span class="element-citation">Finkielstain GP, Forcinito P, Lui JC, Barnes KM, Marino R, et al.  An extensive genetic program occurring during postnatal growth in multiple tissues. <span><span class="ref-journal">Endocrinology. </span>2009;<span class="ref-vol">150</span>:1791–1800.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2659288/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19036884" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Meyer1">35. <span class="element-citation">Meyer JH, Nelson AO. Efficiency of Feed Utilization by Various Animal Species Fed Similar Rations. <span><span class="ref-journal">J Nutr. </span>1963;<span class="ref-vol">80</span>:343–349.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14062654" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Parini1">36. <span class="element-citation">Parini P, Johansson L, Broijersen A, Angelin B, Rudling M. Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system. <span><span class="ref-journal">Eur J Clin Invest. </span>2006;<span class="ref-vol">36</span>:98–104.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16436091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Folch1">37. <span class="element-citation">Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. <span><span class="ref-journal">J Biol Chem. </span>1957;<span class="ref-vol">226</span>:497–509.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/13428781" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Ruiz1">38. <span class="element-citation">Ruiz JI, Ochoa B. Quantification in the subnanomolar range of phospholipids and neutral lipids by monodimensional thin-layer chromatography and image analysis. <span><span class="ref-journal">J Lipid Res. </span>1997;<span class="ref-vol">38</span>:1482–1489.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9254073" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Quackenbush1">39. <span class="element-citation">Quackenbush J.  Nat Genet 32 Suppl; 2002. Microarray data normalization and transformation. pp. 496–501.  <span class="nowrap ref pubmed">[<a href="/pubmed/12454644" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Tusher1">40. <span class="element-citation">Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2001;<span class="ref-vol">98</span>:5116–5121.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC33173/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11309499" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Huangda1">41. <span class="element-citation">Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. <span><span class="ref-journal">Nat Protoc. </span>2009;<span class="ref-vol">4</span>:44–57.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19131956" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Rozen1">42. <span class="element-citation">Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. <span><span class="ref-journal">Methods Mol Biol. </span>2000;<span class="ref-vol">132</span>:365–386.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10547847" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Pfaffl1">43. <span class="element-citation">Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. <span><span class="ref-journal">Nucleic Acids Res. </span>2001;<span class="ref-vol">29</span>:e45.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC55695/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11328886" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Boersma1">44. <span class="element-citation">Boersma B, Wit JM. Catch-up growth. <span><span class="ref-journal">Endocr Rev. </span>1997;<span class="ref-vol">18</span>:646–661.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9331546" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Peake1">45. <span class="element-citation">Peake GT, Birge CA, Daughaday WH. Alterations of radioimmunoassayable growth hormone and prolactin during hypothroidism. <span><span class="ref-journal">Endocrinology. </span>1973;<span class="ref-vol">92</span>:487–493.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/4682861" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Cooper1">46. <span class="element-citation">Cooper DS, Kieffer JD, Saxe V, Mover H, Maloof F, et al.  Methimazole pharmacology in the rat: studies using a newly developed radioimmunoassay for methimazole. <span><span class="ref-journal">Endocrinology. </span>1984;<span class="ref-vol">114</span>:786–793.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/6199191" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Calvo1">47. <span class="element-citation">Calvo R, Obregon MJ, Ruiz de Ona C, Escobar del Rey F, Morreale de Escobar G. Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3&#x02032;-triiodothyronine in the protection of the fetal brain. <span><span class="ref-journal">J Clin Invest. </span>1990;<span class="ref-vol">86</span>:889–899.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC296808/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/2394838" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Knipper1">48. <span class="element-citation">Knipper M, Zinn C, Maier H, Praetorius M, Rohbock K, et al.  Thyroid hormone deficiency before the onset of hearing causes irreversible damage to peripheral and central auditory systems. <span><span class="ref-journal">J Neurophysiol. </span>2000;<span class="ref-vol">83</span>:3101–3112.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10805704" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Lee2">49. <span class="element-citation">Lee EK, Gorospe M. Minireview: posttranscriptional regulation of the insulin and insulin-like growth factor systems. <span><span class="ref-journal">Endocrinology. </span>2010;<span class="ref-vol">151</span>:1403–1408.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2850238/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20032049" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-RicoBautista1">50. <span class="element-citation">Rico-Bautista E, Flores-Morales A, Fernandez-Perez L. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. <span><span class="ref-journal">Cytokine Growth Factor Rev. </span>2006;<span class="ref-vol">17</span>:431–439.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17070092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Ahmed1">51. <span class="element-citation">Ahmed SF, Farquharson C. The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. <span><span class="ref-journal">J Endocrinol. </span>2010;<span class="ref-vol">206</span>:249–259.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20631046" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Waxman1">52. <span class="element-citation">Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. <span><span class="ref-journal">Mol Pharmacol. </span>2009;<span class="ref-vol">76</span>:215–228.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2713118/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19483103" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Rakhshandehroo1">53. <span class="element-citation">Rakhshandehroo M, Hooiveld G, Muller M, Kersten S. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. <span><span class="ref-journal">PLoS One. </span>2009;<span class="ref-vol">4</span>:e6796.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2729378/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19710929" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Castelein1">54. <span class="element-citation">Castelein H, Gulick T, Declercq PE, Mannaerts GP, Moore DD, et al.  The peroxisome proliferator activated receptor regulates malic enzyme gene expression. <span><span class="ref-journal">J Biol Chem. </span>1994;<span class="ref-vol">269</span>:26754–26758.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/7929410" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Tong1">55. <span class="element-citation">Tong L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. <span><span class="ref-journal">Cell Mol Life Sci. </span>2005;<span class="ref-vol">62</span>:1784–1803.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/15968460" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Horton1">56. <span class="element-citation">Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, et al.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2003;<span class="ref-vol">100</span>:12027–12032.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC218707/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14512514" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Vlahcevic1">57. <span class="element-citation">Vlahcevic ZR, Heuman DM, Hylemon PB. Regulation of bile acid synthesis. <span><span class="ref-journal">Hepatology. </span>1991;<span class="ref-vol">13</span>:590–600.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/1847897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Hunt1">58. <span class="element-citation">Hunt MC, Yang YZ, Eggertsen G, Carneheim CM, Gafvels M, et al.  The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis. <span><span class="ref-journal">J Biol Chem. </span>2000;<span class="ref-vol">275</span>:28947–28953.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10867000" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Pelletier1">59. <span class="element-citation">Pelletier P, Gauthier K, Sideleva O, Samarut J, Silva JE. Mice lacking the thyroid hormone receptor-alpha gene spend more energy in thermogenesis, burn more fat, and are less sensitive to high-fat diet-induced obesity. <span><span class="ref-journal">Endocrinology. </span>2008;<span class="ref-vol">149</span>:6471–6486.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18719022" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Lui1">60. <span class="element-citation">Lui JC, Baron J. Mechanisms limiting body growth in mammals. <span><span class="ref-journal">Endocr Rev. </span>2011;<span class="ref-vol">32</span>:422–440.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3365796/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21441345" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Saenger1">61. <span class="element-citation">Saenger P, Czernichow P, Hughes I, Reiter EO. Small for gestational age: short stature and beyond. <span><span class="ref-journal">Endocr Rev. </span>2007;<span class="ref-vol">28</span>:219–251.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17322454" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Davenport1">62. <span class="element-citation">Davenport JW, Hennies RS. Perinatal hypothyroidism in rats: persistent motivational and metabolic effects. <span><span class="ref-journal">Dev Psychobiol. </span>1976;<span class="ref-vol">9</span>:67–82.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/943352" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Vidal1">63. <span class="element-citation">Vidal OM, Merino R, Rico-Bautista E, Fernandez-Perez L, Chia DJ, et al.  In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver. <span><span class="ref-journal">Mol Endocrinol. </span>2007;<span class="ref-vol">21</span>:293–311.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17008382" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Waxman2">64. <span class="element-citation">Waxman DJ, O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. <span><span class="ref-journal">Mol Endocrinol. </span>2006;<span class="ref-vol">20</span>:2613–2629.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16543404" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-FloresMorales2">65. <span class="element-citation">Flores-Morales A, Greenhalgh CJ, Norstedt G, Rico-Bautista E. Negative regulation of growth hormone receptor signaling. <span><span class="ref-journal">Mol Endocrinol. </span>2006;<span class="ref-vol">20</span>:241–253.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16037128" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Schaefer1">66. <span class="element-citation">Schaefer F, Chen Y, Tsao T, Nouri P, Rabkin R. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia. <span><span class="ref-journal">J Clin Invest. </span>2001;<span class="ref-vol">108</span>:467–475.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC209355/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11489940" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Chen1">67. <span class="element-citation">Chen Y, Sun D, Krishnamurthy VM, Rabkin R. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding. <span><span class="ref-journal">Am J Physiol Endocrinol Metab. </span>2007;<span class="ref-vol">292</span>:E1856–1862.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17327369" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Huang1">68. <span class="element-citation">Huang Y, Du M, Zhuang S, Shen Z, Li Y. Impaired growth hormone receptor signaling during non-catch-up growth in rats born small for gestational age. <span><span class="ref-journal">Horm Res Paediatr. </span>2010;<span class="ref-vol">74</span>:106–113.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20395663" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Fraser1">69. <span class="element-citation">Fraser A, Hughes R, McCarthy A, Tilling K, Davies D, et al.  Early life growth and hemostatic factors: the Barry Caerphilly Growth study. <span><span class="ref-journal">Am J Epidemiol. </span>2008;<span class="ref-vol">168</span>:179–187.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18495627" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Shahkhalili1">70. <span class="element-citation">Shahkhalili Y, Moulin J, Zbinden I, Aprikian O, Mace K. Comparison of two models of intrauterine growth restriction for early catch-up growth and later development of glucose intolerance and obesity in rats. <span><span class="ref-journal">Am J Physiol Regul Integr Comp Physiol. </span>2010;<span class="ref-vol">298</span>:R141–146.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19889868" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Chen2">71. <span class="element-citation">Chen LL, Hu X, Zheng J, Kong W, Zhang HH, et al.  Lipid overaccumulation and drastic insulin resistance in adult catch-up growth rats induced by nutrition promotion after undernutrition. <span><span class="ref-journal">Metabolism. </span>2011;<span class="ref-vol">60</span>:569–578.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20619426" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Morrison1">72. <span class="element-citation">Morrison JL, Duffield JA, Muhlhausler BS, Gentili S, McMillen IC. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. <span><span class="ref-journal">Pediatr Nephrol. </span>2010;<span class="ref-vol">25</span>:669–677.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20033220" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Desvergne1">73. <span class="element-citation">Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. <span><span class="ref-journal">Physiol Rev. </span>2006;<span class="ref-vol">86</span>:465–514.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16601267" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Petty1">74. <span class="element-citation">Petty KJ, Desvergne B, Mitsuhashi T, Nikodem VM. Identification of a thyroid hormone response element in the malic enzyme gene. <span><span class="ref-journal">J Biol Chem. </span>1990;<span class="ref-vol">265</span>:7395–7400.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/2332433" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Wang1">75. <span class="element-citation">Wang Y, Yin L, Hillgartner FB. The homeodomain proteins PBX and MEIS1 are accessory factors that enhance thyroid hormone regulation of the malic enzyme gene in hepatocytes. <span><span class="ref-journal">J Biol Chem. </span>2001;<span class="ref-vol">276</span>:23838–23848.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11331288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Yin1">76. <span class="element-citation">Yin L, Wang Y, Dridi S, Vinson C, Hillgartner FB. Role of CCAAT/enhancer-binding protein, histone acetylation, and coactivator recruitment in the regulation of malic enzyme transcription by thyroid hormone. <span><span class="ref-journal">Mol Cell Endocrinol. </span>2005;<span class="ref-vol">245</span>:43–52.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16293364" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Wang2">77. <span class="element-citation">Wang Y, Zhang Y, Hillgartner FB. Chicken ovalbumin upstream-promoter transcription factor and E-box-binding proteins enhance thyroid-hormone responsiveness of the malic enzyme gene in avian hepatocytes. <span><span class="ref-journal">Biochem J. </span>2002;<span class="ref-vol">361</span>:391–400.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC1222320/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11772412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Ho1">78. <span class="element-citation">Ho KK, Gibney J, Johannsson G, Wolthers T. Regulating of growth hormone sensitivity by sex steroids: implications for therapy. <span><span class="ref-journal">Front Horm Res. </span>2006;<span class="ref-vol">35</span>:115–128.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16809927" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Lin1">79. <span class="element-citation">Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, et al.  Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. <span><span class="ref-journal">Hepatology. </span>2008;<span class="ref-vol">47</span>:1924–1935.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18449947" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Heemers1">80. <span class="element-citation">Heemers HV, Verhoeven G, Swinnen JV. Androgen activation of the sterol regulatory element-binding protein pathway: Current insights. <span><span class="ref-journal">Mol Endocrinol. </span>2006;<span class="ref-vol">20</span>:2265–2277.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16455816" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-Larsen1">81. <span class="element-citation">Larsen PR. Thyroid hormone analogs and metabolites: new applications for an old hormone? <span><span class="ref-journal">Nat Clin Pract Endocrinol Metab. </span>2009;<span class="ref-vol">5</span>:1.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19079269" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0037386-BruckerDavis1">82. <span class="element-citation">Brucker-Davis F. Effects of environmental synthetic chemicals on thyroid function. <span><span class="ref-journal">Thyroid. </span>1998;<span class="ref-vol">8</span>:827–856.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9777756" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3354003&amp;issue-id=209567&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3354003/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3354003/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3354003/pdf/pone.0037386.pdf">PDF (731K)</a></li> | <li><a href="#" data-citationid="PMC3354003" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3354003%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3354003%2F&amp;text=Influence%20of%20Neonatal%20Hypothyroidism%20on%20Hepatic%20Gene%20Expression%20and%20Lipid%20Metabolism%20in%20Adulthood"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3354003%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="22666351" data-aiid="3354003" data-aid="3354003" data-iid="209567" data-domainid="440" data-domain="plosone" data-accid="PMC3354003" data-md5="43c18b3b600eca586360ec61d7a41f78"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2018-07-16T19:05:58-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc202&amp;ncbi_phid=F4FC690BB4D241A1000000000055004B&amp;ncbi_session=F4FC690BB4D24D51_0085SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3354003%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosone&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3354003/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC690BB4D24D51_0085SID /projects/PMC/PMCViewer@4.46 ptpmc202 v4.1.r563004 Tue, May 01 2018 03:01:28 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>